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Abstract 
 
 
New paradigms are developed in magnetic resonance imaging for the advanced 
diagnosis of neurodegenerative diseases. In particular, multiple sclerosis (MS) and 
amyotrophic lateral sclerosis (ALS) preclinical research poorly focuses on 
functional connectivity in brain. Available animal models of MS and ALS are 
extensively used for analysis such drug testing and discovery of underlying 
mechanisms of pathogenesis. These diseases present, since neuronal lesions 
formation and neuroinflammation, a multilevel heterogeneity in mechanism of 
neurodegeneration and brain connectivity still not well understood. Moreover, they 
play a key role in pharmacological research, from the identification of a therapy 
target to the in vivo validation of the efficacy. More recently alterations in 
synchronized brain activity at rest in MS patients have been reported. At the best of 
our knowledge, functional imaging has not been applied yet in the assessment of 
new therapies in the preclinical models for MS and ALS. In this study, we aim to 
develop an innovative platform based on functional MRI in the resting state 
(rsfMRI), for the pre-clinical evaluation of new markers in MS and ALS. Moreover, 
the advancing in MRI techniques could assess new criteria of sensitivity and 
specificity in diagnosis; an additional analysis on diffusion MRI outcomes in MS 
preclinical models is added to this study. 
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Introduction 
 
1. Advances in MRI for detecting markers in healthcare and research 
 
The word biomarker is an umbrella term that depicts a “characteristic that is 
objectively measured and evaluated as an indicator of normal biological processes, 
pathogenic processes, or pharmacologic responses to a therapeutic intervention”, 
as defined by the Biomarkers Definitions Working Group (NIH, 1998). This 
definition broadens as large as the progress in clinical and preclinical fields follows 
the discovery of new methods, instruments and analysis processes. A biomarker is 
everything that can be defined as robust, reproducible, and unambiguous, that is 
related to a clinical sign, or support a clinical accepted score in depicting a disease 
or establish a clinical onset.  
They can be prognostic, diagnostic or acquired at specific timepoints. When clinical 
trials and research deal with diseases which effects are prolonged in time, or they 
are treated for the whole lifespan, new markers, named as surrogate biomarkers can 
be crucial to check therapies effects in trial phase and avoid false negative results 
from previously assessed measurement (Strimbu and Tavel, 2011).  
Surrogates, by definition are “ laboratory measurement or physical sign that is used 
in therapeutic trials as a substitute for a clinically meaningful end point that is a 
direct measure of how a patient feels, functions or survives and is expected to 
predict the effect of therapy" (Temple. 1999). 
They were introduced because of the necessity to supplement relevant information 
due from other biomarkers; moreover new techniques in imaging could provide 
useful primary outcome measures. In magnetic resonance imaging (MRI), 
biomarkers are related to quantitative values derived from advanced methods of 
signal detection, or they are related to indirect measures that need to be correlated 
with other biomarkers, or other techniques. MRI provide in-vivo as well ex-vivo 
results; in one image is possible to investigate features of pathology, and it is 
possible to discover other findings related to a disease not only qualitatively, but 
also dynamically, i.e. across time.  
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MRI is well known as technique in check-ups and differential diagnosis when other 
instruments lack of resolution, to investigate or discriminate di per se tissues in 
details, non-invasively. MRI outcomes are also combined with other instruments, 
such as computerized axial tomography, single photon emission computer 
tomography, ultrasound imaging. In particular, the detection of pathological 
features in tissues, vessels or organs can be enhanced by means of specific contrast 
agents.  
While other imaging techniques can achieve a preliminary diagnosis without MRI, 
following an event with poorly understood clinical signs, or with confounding 
symptoms at its acute stage, remains challenging. Moreover, it becomes crucial 
defining biomarkers and their surrogates also to assess the correct strategy for 
surgery and pathologies that need fast treatment. In addition, contrast agents 
normally used in clinics not always are specific and they do not determine directly 
the progress of diseases. Often the definition of biomarkers is oriented towards 
molecules that can interact with a treatment, or change during the progress of a 
disease; to date biomarkers are investigated on univocal “objects” that possess 
unambiguous features, or exhibit specific activity. Some antigen tests remain 
controversial (Hall, 2017), and not all the neuropathologies have clear markers in 
vivo. 
Biomarkers related to functional brain decline are poorly correlated with other 
parameters for diagnosis. To note, in neurodegenerative diseases derived from 
autoimmunity or genetic mutation processes, clinical scores or endpoints in 
disability scale are the result of values from multiple tests. In particular, 
neuropathologies related to accidents (e.g. stroke), injuries (concussion), systemic 
inflammation (autoimmunity, viral infection secondary effect), iatrogenic effects 
(surgery) or aggressive treatments (radiotherapy, chemotherapy, 
immunomodulatory drugs), that lead to progressive neurodegeneration, are not well 
understood. Thus remains important to address efforts to prevent neurological 
disabilities in patients, as well as the research of   new biomarkers that could state 
a difference between healthy and compromised nervous system, from different 
points of view. For example, neuroimaging techniques can assess the morphology, 
the microstructure, the microenvironment of the brain and its lesions (Tab.1.1).  
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Different metrics can be diffusion metrics within the tracts, counted number of 
tracks, connection probability between brain regions. In case of functional 
neuroimaging, metrics can refer for example to correlation coefficient, or quantify 
how signals covary between regions belonging to a particular functional network. 
 
Method Neurodegenerative feature 
 Neuronal/axonal loss 
Myelin 
disruption 
Gliosis Iron content Connectivity 
T1 w 
Atrophy; diameter, area, 
volumes, automated 
volume analysis 
    
T2 w Atrophy   
Signal 
increase  
Signal decrease;  
R2 increase 
 
NM-MRI  
Signal decrease;  volume, 
signal intensity 
    
MTI MTR MTR    
Diffusion 
imaging 
MD, FA, AD, FW FA, RD MD, FW  Structural  
Iron-
sensitive 
sequences 
   
Signal decrease, 
anatomical 
structures (DNH); 
different metrics 
 
1H-MRS NAA, NAA/Cho, NAA/Cr Cho    
rs-fMRI     Functional  
ASL     Functional  
 
Table 1.1 Adapted from Heim, Krismer et al, 2017. Qualitative markers are in italic, while their 
outcomes are in bold; Abbreviations: AD axial diffusivity, ASL arterial spin labelling; Cho 
choline, rCBF regional cerebral blood flow, Cr creatine, DNH dorsolateral nigral hyperintensity, 
1H-MRS proton magnetic resonance spectroscopy, FA fractional anisotropy, FW free water, MD 
mean diffusivity, MTI magnetization transfer imaging, MTR magnetization transfer ratio, NAA N-
acetylaspartate, NM-MRI neuromelanin-sensitive MRI, R2 T2 relaxation rate, R2* T2*  relaxation 
rate, RD radial diffusivity, rs-fMRI resting-state functional MRI. 
 
In preclinical research, when rodent central nervous system is main research focus, 
studies are conducted to discover features to assess if experimental therapeutic 
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interventions are more successful in preventing and delaying disease, without 
clinical manifestation, heterogenic signs or before a true clinical outcome.  
Nowadays neuroimaging neuropathology correlations can be improved by means 
of new computational methods. Image processing, as well as image analysis from 
different MRI methods can extract new useful metrics to understand clinical course 
of brain pathologies, both in human and rodents. The aim of the study reported in 
this manuscript is to assess robustness of new MRI techniques for different rodent 
models of pathologies with poor clinical signs at their prodromal stages in brain. In 
this study, early biomarkers in neuroimaging are investigated by means of different 
MRI methods. In particular, two available models of multiple sclerosis (MS) are 
used, to unravel immunity outcomes in mouse brain, i.e. if they can be clearly 
assessed with in vivo and ex vivo imaging. Moreover, also amyopthropic lateral 
sclerosis (ASL) model is taken in account to assess MRI markers, to understand the 
development of the disease in rodents brain.  
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1.2 MRI findings on Multiple Sclerosis and Amiotrophic Lateral Sclerosis 
 
1.2.1 Multiple Sclerosis preclinical associated models 
 
To compare, morphological biomarkers can measure longitudinally brain atrophy 
in multiple sclerosis and volumetric and numerical analysis of plaques, in T2 and 
T1 contrast enhanced imaging.  
MS affects the central nervous system (CNS). This disease lead to myelin, 
oligodendrocytes, axons and neurons damage. Nowadays MS is considered as a 
generalized neurodegenerative process that involves not only the CNS. MS 
diagnosis follows assessed criteria (for a general disability scale and measures, see 
Uitedaag, 2018). Generally, MS is discovered because of deambulatory issues, 
optic nerve or spinal cord inflammation in patients, and confirmed with  a MRI 
scout scan. Routinary imaging of the brain after the diagnosis  is used to monitor 
the progression of this disease, but it does not exclude a cumulative 
neurodegeneration process. Original benchmarks to avoid false-positive diagnosis 
rely in cerebrospinal fluid, combined to the assessment of brain lesion across time 
and space (Polman, Stephen et al, 2005). Moreover, it can be distinguished in 
relapsing-remitting and chronic MS, thus the need to eliminate alternative 
conditions persist, by means of differential diagnosis. Biomarkers are used to assess 
MS and exclude for example, neuromyelitis optica, by means of specific serum 
antibody (Lennon V, Wingerchuk D, et a., 2005). MS diagnosis, considering 
revised criteria, is satisfied with at least one gadolinium-enhancing lesion or nine 
T2 hyper-intense lesions without gadolinium enhancing. Also infratentorial, 
juxtacortical lesion, with at least three periventricular lesions are added to 
demonstrate dissemination of lesion in space (Barkhof, Filippi M, Miller DH, et al., 
1997; Tintoré, Rovira, Martinez, 2000). These criteria open considerations on other 
MRI findings, also incorporating spinal cord imaging, that can be used as criteria 
for the disease assessment in time. New techniques focuses on sensitivity and 
specificity, such as diffusion weighted imaging, and functional connectivity in the 
brain as non-invasive inspection of changes in normal, healthy brain activity. 
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Main used preclinical models for MS are based on experimental autoimmune 
encephalomyelitis (EAE) development. They can be classified accordingly to 
method used to induce the disease. Major EAE induced in mice used are myelin 
oligondendrocyte (MOG) mediated by pertussis toxin, PLP protein mediated, 
adoptive cell transfer (for a general overview, see Hart, Ganz and Weissert, 2011) 
EAE toxic demyelination cuprizone is extensively used for myelin damage studies 
(Torkildsen et al., 2008). 
The interaction between the immunopathological and neuropathological features 
permits to consider different approximative mimicking MS EAE models across 
laboratory species. 
Induced EAE in mice shares features that are related to human outcomes in MS 
condition; these are inflammation, demyelination, axonal degeneration and gliosis. 
Up to date, these processes are still investigated. For example, inflammatory 
demyelination is not directly implied in perilesional axonal damage (Singh, 
Dallenga, Winkler et al., 2017), or axon transection in EAE is restored by reactive 
oxygen species and nitric oxide species (ROS/NOS) scavengers (Sorbara, Wagner, 
Ladwig et al., 2014). Moreover, in humans CD8 cells drive the autoimmune disease 
in MS, while CD4 are the major infiltrates in EAE model. Thus this 
“immunological” gap, as well the susceptibility to EAE induction and the response 
variability, suggest to focus on to the specific aspects of tailored preclinical model, 
to improve the selection of therapies. Moreover, if immunological aspects of each 
EAE model used were clarified, not all the treatments were successfully translated 
to humans (Segal, 2008) and some therapies with the progression of MS decay in 
efficacy (Hemmer, Mulau, 2016).  
The variability in EAE neuroimmunology creates an opportunity to explore in a 
different manner inflammation and de-myelination. The possibility to robust 
clinical scores, with a standardized method, has brought research efforts towards 
the analysis of all the weaknesses inherent to EAE models from the immunological 
point of view, more than focusing on intrinsic protective mechanisms and brain 
dysfunctions in rodents.   
EAE mice models have been investigated by means of other MRI techniques, such 
as magnetization transfer ratio (Aharoni, Sasson et al, 2013), voxel based 
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morphometry (Hamilton, 2019), T2 weighted imaging with contrast agent (Belloli, 
Zanotti, Murtaj et al., 2018). Diffusion imaging, as well as functional and resting 
state MRI methodologies are used in human studies (Cortese, Collorone, Cicarelli 
et al, 2016), but at the time this study started no reports in EAE mouse brain use 
resting state functional imaging at low magnetic field, or ex-vivo diffusion imaging 
at higher magnetic field. MRI investigation on EAE models are conducted both in-
vivo and ex-vivo, to investigate myelin damage during the disease course. A 
summary of MRI on EAE cuprizone model highlight also some ex-vivo structural 
study, but a majority of papers focused on some regions, such corpus callosum, 
cingulate and cortex. (Tab. 1.2). At the time of this work, ex-vivo MRI in EAE mice 
is poorly investigated, but research in neuroimaging values focused on myelin 
change during the disease is still ongoing. All aim to detect disease biomarkers, or 
retrospective metrics, in human MS, especially to monitor lesions course.  
Reference In-/Ex-
vivo 
Acquisition Analysis  Methods 
Chandran et al. (2012) In MS CC, Cg, EC T2w, DTI 
Falangola et al. (2014) In MS CC DKI 
Fjær et al. (2013) In 3D CC, GM, Cbl, 
Ctx 
T2w, MTR 
Guglielmetti et al. (2016) In MS CC, Ctx T2w, DKI 
Jelescu et al. (2016) In SS CC T2w, MTR, DKI 
Merkler et al. (2005) In 3D CC, EC T1w, T2w, MTR 
Song et al. (2005) Ex MS CC, EC, OT, CP DTI 
Sun et al. (2006) In MS CC DTI 
Tagge et al. (2016) In 3D Cbr T2w, MTR 
Thiessen et al. (2013) Both SS CC, EC, Ctx T1/2, qMT, DTI, 
MWF 
Torkildsen et al. (2009) In MS Lesion volumes T2w 
Turati et al. (2014) In SS×2 CC, EC qMT 
Wood et al. (2016) Ex MS CC, Cbl T1w,T2w, DTI, MWF 
Wu et al. (2008) In MS CC T2w, DTI 
Xie et al. (2010) In MS CC DTI 
Zhang et al. (2012) Both 3D/MS CC, Ctx T2w, MTR, DTI 
Tab.1.2. Review of cuprizone mice volume analysis and MRI methods. adapted from 
Wood, Simmons et al., 2016. Cbl, Cerebellum; Cbr, Cerebrum; CC, Corpus Callosum; 
8 
 
EC, External Capsule; Ctx, Cortex; Cg, Cingulum; DKI, Diffusion Kurtosis Imaging; 
DTI, Diffusion Tensor Imaging; CP, Cerebral Peduncles; MS, Multi-slice; MTR, 
Magnetisation Transfer Ratio; MWF myelin water fraction; OT, Optic Tracts; qMT, 
Quantitative Magnetisation Transfer; SS, Single-slice; T1w, T1 Weighted; T2w, T2 
Weighted; T1, T1 Map; T2, T2 Map;  
 
 
 
1.2.2 Amyotrophic lateral sclerosis (ALS) preclinical associated models 
 
ALS is a neurodegenerative disease that involves the motor neuron, a network in 
CNS that involves spinal cord and primary motor cortex in brain. 
Neuropathological outcomes are degeneration of upper and or lower motor neurons. 
Onset symptoms refers to progressive weakness and progressive paralysis of other 
muscular districts also involved in breathing, causing ALS to be a fatal and 
incurable disease (Mitchell  and Borasio, 2007). Moreover, other symptoms related 
to ALS are associated to extra-motor areas in brain, such as behavioural and 
cognitive changes, with concomitant psychiatric disorders observed at the onset of 
the disease (Zucchi, Ticozzi and Mandrioli, 2019). 
Is it widely recognized that ALS bear autonomic and extra-motor disabilities and 
this diagnosis is distinguished in subtypes, with shared symptoms with fronto-
parietal dementia and parkinsonism (Talbot et al., 1995; Neary, Snowden, Mann, 
2000).  Pure motor neuron involvement is overcame by clinical, pathological and 
genetic features of ALS, that should be considered as a multisystem disorder. 
In ALS, to date, only electromyography supports the diagnosis, while animal 
models have not been able to predict response to emerging treatments in humans, 
but clinical endpoints in MRI have been explored in research, by means of 
functional MRI (fMRI), diffusion imaging, without replication in larger cohorts and 
in absence of symptoms (Menke, 2017). 
Despite ALS has sporadic etiology, a part of patients inherits a familial form that is 
related to a gene encoding superoxide dismutase 1 protein (SOD1, see Fridovich, 
1986). Human Cu-Zn superoxide dismutase mutation differs from binding site 
expression (Wang, Xu, Gonzales et al, 2002). 
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Different animal models can reproduce ALS features. They can be subdivided in 
different phenotypes and carry mutations such as fused in sarcoma RNA-binding 
protein FUS, SOD1, TARDBP, ubiquilin 2 - UBQLN2, VAMP-associated protein B 
- VAPB and valosin-containing protein – VCP.  
Also there are other physiological ALS models, obtained by means of mutagen N-
ethyl-N-nitrosourea (ENU, Joyce et al., 2014) (Tab.1.3). 
 
Gene mutation Clinical outcomes in mice Reference 
FUS Delta14 MN loss, diffuse MW Devoy et al., 2017 
SOD1(93A) MN loss, diffuse MW, end stage 
paralysis 
Gurney et al., 1994 
UBQLN2 MW,forelimb/hind atrophy  Deng et al., 2011 
VAPB MN loss, MW, forelimb/hind atrophy, 
end stage paralysis 
Nishimura et al., 2004 
VCP MW, forelimb/hind atrophy Yin et al., 2012 
Table 1.3. Schematic reference showing pathology in ALS models related to carried mutated gene. 
MW: muscle weakness, MN: motor neuron. 
 
The first transgenic line and most studied ALS model is from mouse carrying a 
point mutation in amino acid position 93 of the SOD-1 protein (93A) (Gurney, Pu, 
Chiu et al., 1994), with a life expectancy up to 150 days.  
MRI on SOD (93A) focused on spinal cord structural changes (Fogarty, Mu, Noakes 
et al., 2016), or diffusion properties (Niessen, Angenstein, Sander et al. 2006). Also 
research focused on brainstem at 4.7T magnetic field, from morphological point of 
view (Zang, Yang, Wang et al., 2004), and T2 relaxation time (Bucher, Braunstein, 
Niessen et al., 2007). T2 weighted imaging has already shown its potential as 
biomarker in pre-symptomatic mice at motor , hypoglossal and facial nuclei lesion 
enhancement (Evans, Serres, Khrapitchev et al. 2014), and correlates with diffusion 
tensor imaging metrics associated to histological findings of vacuolization and 
cranial motor neuron T2 hyperintensity (Caron, Micotti, Paladini et al. 2015).  
Up to date, also behavioural studies were conducted on SOD93A, without imaging 
or functional connectivity investigation (Kreilaus , Guerra , Masanetz  et al., 2019). 
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With these assumptions, new biomarkers in rsfMRI can be explored as pre-emptive 
findings in such pathologies to a better understanding of the SOD93A animal model 
comparable to ALS.  
To a better understanding of MRI methods used, the basic principles and methods 
are further discussed, as well as how they are applied to three different 
neuropathological disease models. 
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1.3 Principles of MRI  
 
The first human body scan was proposed by Damadian in 1971, while the MRI 
technique was initially named zeugmatography (Lauterbur, 1975), leading to the 
physical basis of non-invasive in-vivo structural analysis of soft tissues. The MRI 
instrument is a combination of different units. It can be subdivided as follows:  
a) static magnetic field, that is conventionally fixed along z-axis;  
b) x, y, and z-gradients coils and amplifiers, that apply linear magnetic fields along 
space directions 
c) a shim unit, to avoid field inhomogeneities during the acquisition;  
d) radiofrequency electronics block, coupled with an analogic to digital converter;  
e) computer, operator controlled and latest display of the generated signals (Fig.1). 
  
 
Figure 1.1 Schematic representation of a MRI scanner (tomograph). Adapted from 
https://www.rdm.ox.ac.uk/. 
 
MRI relies in quantomechanics principles, applied first in biochemistry and organic 
chemistry (for extensive explanations, see Keeler, 2005 and Levitt, 2008). This 
permits the fine detection of nuclei with determined gyromagnetic ratio, especially 
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hydrogen protons because of higher abundance in biological samples, when they 
are subjected to a fixed magnetic field along an axis. The phenomenon of resonance 
occurs if radiofrequency excitation pulse satisfies Larmor equation. Emitted or 
absorbed energy by atomic nuclei is registered and specific signals rise in the 
frequency spectra. If field gradients are applied in time coincidence with a proper 
radiofrequency pulse to a sample in a fixed magnetic field, nuclear species from the 
sample change their magnetizations, that later decay to reach the energetic 
equilibrium. The time constants for this decay processes phenomena are named 
relaxation times, T1 and T2 respectively. Relaxation times properties give the 
possibility to differentiate various tissues in the body, i.e. generate contrast, that is 
affected also by magnetic field strength, temperature and signal to noise ratio 
(SNR). The constant magnetic field power is expressed in Tesla units (T); for 
humans, the most used electro-magnet has a field of 1.5 T or 3T, valuable for 
clinical purposes, while research combines also human scanners with 7T field. For 
preclinical research, more options are available, from 7 T up to 16.1 T systems 
dedicated to rodents, non-human primates mostly, for high-resolution images. 
A good tissue contrast is achieved by means of an appropriate pulse sequence. 
Major parameters to set for the MRI acquisition are the repetition time (TR), echo 
time (TE), flip angle and inversion time. Briefly, the combination of set TR, TE, 
flip angle are required to acquire MR signal. TR is the amount of time between first 
RF pulse and the same repeated and applied to the selected slice, while TE is crucial 
for the measurement of spins in phase, because it is the time between the 90° RF 
pulse and MR signal sampling, corresponding to maximum of the echo. TE is a 
value between the 90° excitation pulse and echo peak given by excited nuclei, 
expressed in milliseconds. Inversion time is set for water and fat suppression and it 
represents the period between an inversion pulse of 180° (when macroscopic 
magnetization is not aligned to the constant magnetic field, named refocusing pulse) 
and the 90° pulse. Flip angles values define the rotation of net magnetization to the 
main magnetic field. Signal values are dependent of flip angle also: for example, 
for a T1 weighted image, a small flip angle maintains the longitudinal 
magnetization, while the in-plane (z) magnetization is tilted in the x-y planes. If the 
TR is short, the z-magnetization cannot fully recover. As the result of preselected 
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parameters, the free induction decay signal (FID) is acquired and processed by the 
analogic to digital converter. Planes in a selected slice are defined as phase encode 
and frequency encode. The frequency encoding is dependent from FID sampling, 
while the final resolution of the image is dependent from the matrix size, magnetic 
field strength and voxel size. To a better understanding of events occurring inside 
the scanner, an MRI experiment can be decomposed in the pulse diagram (Collins, 
2016, for in-depth fundamentals). 
The MR image is the result of a Fourier transform of the varying signals, in the 
temporal domain, that are decoded back into the frequency domain. When magnetic 
gradients are applied, they cause a phase shift of the protons involved, upon the 
proton RF. The generated signal can be located and encoded in two dimensions. 
Unprocessed signal is stored in the k-space, a formalism introduced to indicate a 
matrix in which the k-x axis contains the frequency data sets and the k-y axis the 
phase encoded ones (Likes, 1979; Twieg & Ljunggren, 1983). 
The sample is scanned along three directions, and sliced in volumes, with the same 
length. This means that the obtained image contains informations not only of the 
acquired MR signal, but also about spatial resolution, data size, field of view (FOV). 
The spatial resolution of an image is defined by voxels. Voxels can be imagined as 
solids in which the depth is represented by the slice thickness. Data size is defined 
by matrix size (MTX), and it is dependent from frequency encoding step number. 
FOV is the covered area by phase matrix and frequency encoding. In-plane voxel 
size is obtained dividing the FOV by the matrix size. Thus means that resolution 
decreases when the voxel size increases, and when FOV increases in both 
directions.  
Depending on the metrics that can be obtained from contrasts, a variety of 
sequences is available for in-vivo and ex-vivo imaging.  
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1.3.1 MRI sequences 
 
Mostly used pulse sequences can be inserted in two MRI macro group methods, 
namely spin and gradient echo imaging. All methods achieve echoes, i.e. the energy 
emitted by nuclei after excitation, as magnetic resonance signal, translated after in 
an image.  
Spin echo or multi-echo sequences are used for anatomical imaging, tissue 
morphology and qualitative abnormalities during pathologies. Susceptibility 
artifacts or noise are lowered by means of one or more 180° RF pulses, after the 
90° pulse. Spins are refocused, generating signal echoes. Methods can vary 
accordingly to instrument manufacturing or commercial implementation. For 
example, fast or turbo spin echo sequences include the Rapid Acquisition with 
Refocused Echo (RARE, Hennig et al., 1986). 
In the same group, multi echo imaging permits to measure the T2 relaxation time. 
The sequence used is a spin echo, multi echo multi slice (MEMS).  
Gradient echo imaging, instead of spin echo, lacks of 180° refocusing pulse, 
because of magnetization tilting by a flip angle between 0 and 90°. An echo is 
generated by means of bipolar gradient pulses, because of spin dephasing by 
applying a negative pulse gradient, followed by spin rephasing, achieved by an 
applied opposite gradient. T2 weighted imaging by GE are more sensitive to field 
inhomogeneities, compared to SE. 
A GE sequence weighted in T1 is the three dimensional Magnetization Prepared 
Rapid Acquisition Gradient Rapid Echo (3D MPRAGE). It is an inversion recovery 
sequence (by an applied 180° inversion pulse) followed by a GRE imaging 
sequence, in which a secondary phase encoding, towards slice selection direction, 
is introduce to produce 3D images. In this case, higher magnetic fields, respect to 
transmitted field, cause spatial inhomogeineities that are corrected with double 
imaging and two inversion times, namely MP2RAGE (Marques et al., 2010). 
Inversion time is used for fluid suppression, or T1 weighted images.  
The earliest GE sequence, nowadays applied for diffusion, perfusion and functional 
MRI, was developed to achieve Echo Planar Imaging (EPI), (Stehling, Turner and 
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Mansfield, 1991) and it is characterized by a periodic frequency encoding gradient 
reversing. 
The short sequence time permits faster data acquisition, that is with one TR the 
possibility to fill k-space lines, while other pulse programs utilize also phase 
encoding step for signal sampling. Drawbacks are related to image resolution, 
which is dependent from ramp gradient sampling. The machine requires high field 
strength and good hardware; major artifacts are due to gradients, as phase 
accumulation across the scheme sequence, and the results are not only in image 
distortion but also the water fat shift in the phase encoding direction. This method 
is useful in brain and other techniques that requires fast imaging, such as functional 
MRI in humans and small animals.  
 
1.3.2 Functional MRI 
 
Functional MRI (Amaro & Barker, 2006) is a method to see where neural activity 
is present, using protocols with fast scanning at low space resolution. This 
technique is used to determine insights in both basic workings and malfunctions of 
the brain, and represents an innovative approach in experimental psychology and 
neurophysiology. The monitored brain response by fMRI has been extended to 
other purposes, enabling the possibility of investigated activated areas of the brain 
with specific spatial localization. It is important to recall that the interaction 
between gradients and neuroimaging has to be considered, i.e. artifacts generated 
by sequence used, head movement, cerebral blood flow. 
Brain perfusion changes result in observable alterations in the distribution of de-
oxyhemoglobin/haemoglobin in the red blood cells. The contrast generated in MRI, 
is named blood oxygenation level dependent (BOLD): working tissues “dissolve” 
CO2 when working, thus low pH environment leads to positive charge in the 
histidine-heme complex, with consequent oxygen release in the bloodstream. This 
paramagnetic effect was observed in brain vessels (Ogawa, 1990). The MRI 
contrast is dependent from the different magnetic susceptibility of blood inside the 
vessels, which is non-parallel oriented to the static magnetic field. The overall 
processes, in GE sequences, generates effects in the water signal, which is detected 
16 
 
as contrast in brain. Therefore BOLD contrast is related to the hemodynamic 
response and neuronal activity can be monitored by MRI (Logothetis et al., 2001). 
Studying the already know mechanism of neurovascular coupling, local variation 
of blood supply can be correlated to anatomical regions. The structural part in an 
fMRI experiment is provided by a T2w high resolution image of the same subject.  
If it is easier to distinguish a difference in hemodynamic response between task-
evoked imaging and rest-imaging, because the latter one informs about the first, and 
it is demonstrated that increased brain activity corresponds to a higher oxygen 
demand, that results in MRI initial signal attenuation (dip) followed by an increase. 
The susceptibility between blood and tissue changes because of different ratios of 
oxygenated and de-oxygenated blood (fig.1.2). 
 
Figure 1.2. Bold effect (adapted from Barth, Poser, 2011); I, II, III corresponds to BOLD response 
steps in change. HbO2 oxigenated haemoglobin, Hb de-oxygenated haemoglobin. 
 
The origin of resting state functional MRI (rsfMRI) has derived from BOLD signal 
noise source studies and vascular variability investigation in brain, in fMRI 
paradigms. Resting state functional connectivity was observed first in humans 
(Biswal, 1995).  
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The hypothesis of common hemodynamic “substrate” both in task and rest imaging 
was assessed focusing on sensorimotor cortex, that exhibited a constant activity 
correlated to visual and auditory cortices tract (Hampson, 2002). 
RsfMRI is based in BOLD contrast also, but studies the low signal fluctuations in 
brain activity, with frequencies in the range of 0.01-0.02 Hz, that can observed 
during cognitive task or neurological/psychiatric disorders.  
Moreover, long-range connection between functional areas are related to resting 
state, and both positive and negative correlations between regions showed 
spontaneous low frequencies, even if not anatomically correlated; one latter 
hypothesis is related to neuron subsets and Na+/K+ ion concentrations, that produce 
membrane voltage fluctuations (Krishnan, González and Bazhenov, 2018). 
To investigate the brain from the functional point of view can provide new findings 
about neuronal networks at long scale level. Studies that benefits from rsfMRI 
outcomes are related to behaviour, neurosciences applied to psychology, or 
neurodegenerative diseases with non evident signs at prodromal stage, i.e. ALS, 
(Ogura, Watanabe, Kawabata, 2019) and Parkinson (Westphal, Simmons 2017; 
Chen, 2015) (Heim, De Marzi, Seppi, 2017).  
Since the first studies conducted on resting state, basal brain activity can be 
subdivided in networks, that are anti-correlated one to each other. A major 
hypothesis consider an intrinsic brain network and an extrinsic one, but they are not 
always equivalent and they do not always correlate when task are performed 
(Mennes, Kelly, Colcombe et al., 2013). The intrinsic network corresponds to 
default mode network (DMN), that is present also in rodents (Stafford, Jarrett, 
Dominguez et al., 2014). 
From module stability maps in resting state experiments from a high cohort of C57 
mice, functional hubs were extracted from brain. Anatomically, they can be 
distinguished in default mode network (Retrosplenial cortex, cingulate area, 
tegmental area, prefrontal cortex are involved), lateral cortical (somatosensory 
lateral area; motor area; frontal area), hippocampal (ventral and dorsal gyrus of 
hippocampus; thalamic portion and dentate gyrus of hippocampus), Basal forebrain 
(sensorimotor area, nucleus accumbens); Ventral Midbrain network (comprehends 
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tegmental decussation, Amygdala, Hypothalamus) and Thalamic network (ventral 
thalamic area).  
Interestingly, the DMN is connected more than the lateral cortex network, with 
other hubs of connectivity. Thus means that the two modules can be considered as 
two major intrinsic and extrinsic networks as in human brain, to be further 
investigated (Liska, Galbusera, Schwarz et al., 2015). 
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2. Materials and Methods 
 
This chapter covers in detail all methodologies used for the performed studies. In 
particular, it is subdivided in different sections that specify in detail animal modesl 
used, MRI modality and analysis. Each sub-sections can be referred to the results 
reported in chapter n.3. Reagents are reported in the appendix of this thesis. All 
experiments performed are reported in figure 2.1 for a better understanding. MRI 
methods used for each study were followed by different image analysis procedures.  
 
 
Fig.2.1 Workflow for each study, purple boxes represents available models, used methods 
in green boxes, analysis of different outcomes in MRI are shown in blue boxes, while 
main purpose is in grey boxes; to note, each mouse model was studied with the same 
number of controls (2). AD, axial diffusivity; BOLD blood oxygen level dependent 
signal, EAE, experimental autoimmune encephalitis T cell 17 mediated; EAE (MOG), 
experimental autoimmune encephalitis - myelin oligodendrocyte glycoprotein mediated; 
FA fractional anisotropy, MD, mean diffusivity, RD, radial diffusivity; rsfMRI, resting-
state functional MRI; T1 relaxation time, spin-lattice; T2 relaxation time, spin-spin.  
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2.1 EAE induction by Th17 adoptive transfer 
 
2.1.1 Selection of 2D2 positive mice for cell extraction 
  
For the EAE induction in C57BJL6 mice, T-helper 17 cells from 2D2 positive mice 
were intraperitoneally (i.p.) injected at the clinical neuroscience site in the Centre 
Hospitalier Universitaire Vaudoise Facility (Epalinges site, Lausanne, CH). Mice 
colonies were obtained from 2D2/BJ6 starting couples (Jackson Laboratories), 
crossed with C57BlJ6 wild type strain. Newborn at 1 month of age were genotyped 
by means of flow cytometry. This immunofluorescent staining assay on red blood 
cells (RBC) is an alternative method, instead of DNA extraction, because of the free 
availability of a cytometer inside the facility (BD FACS LSR II Diva, Bethesda, 
US). Two drops of blood for each subject were collected by means of 
submandibular punction, with sterile lancets (Goldenrod, GR 4mm, Braintree 
scientific, US), in ethylene-diamine-tetra-acetic acid (EDTA) tubes, and 
immediately transferred in Eppendorf tubes containing 100 uL of RBC lysis Buffer 
1X. Tubes were spinned at 4°C and kept in ice. Some blood drops were kept for 
unstained control. After a centrifugation at 400g for 4’, lysis was stopped by adding 
200 uL of PBS and the cells were spinned again at 400G for 4’. The supernatant 
was discarded and the pellet was first re-suspended in 50uL of lysis buffer and 
transferred in FACS plate for an incubation of 5’ at room temperature. Lysis was 
immediately stopped by adding 100ul of PBS 1x and the whole content was spinned 
at 400G for 4’. Supernatant was again removed by pipetting and cell pellets were 
re-suspended in 10µL blocking solution, made with  blocking agent (purified 
antimouse monoclonal antibody CD16/32, eBioscience, in 1/100 in FACS buffer) 
and samples were incubated on ice for 15‘ prior to immunostaining. The antibody 
is responsible for blocking CD16/CD32 interactions with the Fc domain, named 
also receptors, of immunoglobulins and is specific to the common epitope of 
CD16/CD32. It is used for blocking non-specific binding of immunoglobulin to Fc 
receptors. (Buchwalow, 2011). 
Antibody mix for surface staining was added to the sample, for each mouse, for the 
amount of 10uL volume in FACS wells, that contained the conjugates to detect CD4 
21 
 
expression with the associate integrin: CD4-PE and  V3α3.2-APC, in dilution 1/100 
respectively. The FACS plate was kept for 15 minutes on ice, away from the light, 
then it was spinned at 400G for 4 minutes. The surnatant was removed and for each 
well was added paraformaldeylde (PFA) 1% on phosphate buffer saline (PBS) at 
pH 7, for 30 minutes on ice. The last step before flow cytometry consisted in 
centrifugation again at 400G for 4’, a FACS buffer wash of the plate, followed by 
spinning the sample at 400G for 4’. After surnatant removal, pellet was resuspended 
in 200uL FACS buffer. After FACS qualitative analysis, mice were splitted in new 
cages and classified as 2D2 positive and 2D2 negative in order to obtain CD4 cells 
that exhibits encephalopathogenic properties after correctly polarization. 
 
2.1.2 In vitro differentiation and proliferation of effector T-cells  
 
To obtain effector T cells, two signals are required. The first one is provided by 
means of interaction of TCR/CD3 complex with major histocompatibility complex 
(MHC) molecule: to present this, in the cellular colture specific antibodies are 
added. The second signal is co-stimulation, provided via interaction of specific 
cluster of differentiations (CDs) and interleukins of T cells with other CDs from 
antigen presenting cells. Freshly isolated splenocytes contains 1-2% of myeloid 
derived dendritic cells (DC). DC express CD80 constitutively, thus representing the 
best adapted to perform functions of antigen presenting cells (APCs). After DC 
irradiation, they remain live in the culture during several days. DCs bind anti-CD3 
antibodies via Fc-receptors, thus T cells in the culture are with both ligands, 
necessary for activation. After 1 to 2 hours, T cells will be express CD40L on them 
because of the signal given by the interaction of TCR/CD3. Interacting with CD40 
on the APCs, this ligand induces additional expression of CD80 and CD86 on 
APCs, including the ones which did not express CD80 and CD86 before. 
CD40/CD40L interaction turn on production of anti-apoptotic molecules in APCs, 
allowing their better survival in culture. CD28 co-stimulation induces production 
of anti-apoptotic molecules, IL-2 and CD25 in T lymphocytes. CD25 expression 
has a role in the formation of receptors with high affinity to IL-2 in T cells 
proliferation of T cells becomes more autonomous and less dependent from co-
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stimulation for at least 48 hours. These processes take place in CD4 and CD8 T 
cells. In order to obtain CD4 T cells, because this process affects also CD8 cells, 
CD4 are isolated and re-stimulated to reach T-helper 17 status. The molecular 
requirements and the methods from naïve cells are summarized in figure 2.1 and 
the presented protocol was adapted from previous literature (Jaeger et al., 2009). 
 
Figure 2.1. B cell differentiation and T-cell polarization method used driven by different molecules. 
Th17 exibit receptors and express different specific factors. Adapted from R&D Biosystems, 2012. 
 
2D2 mice of 10-12 weeks were deeply anesthetized in order to reach the surgical 
protocol for sacrifice, with a mixture of barbituric in saline solution (pentobarbital 
100 mg/gr in NaCl physiological solution per mice). After cervical dislocation, 
spleen, axillary and inguinal lymphnodes were collected to achieve the maximum 
harvesting of B-cells. At the same time, the 2D2 negative mice spleen and lymph 
nodes were collected in order to obtain the correct factors for T-cells culture 
stimulation. 
2D2 positive and negative mice organs were subjected to mechanical extraction via 
cell strainer with a 70uM filter (FALCON). Once organ tissues and fat were 
separated by thawing, the cell strainer was washed with clone media. The enriched 
washing in cells was collected in falcon tubes of 50mL volume. The obtained cells 
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suspension for the pooled mice were incubated on ice with 5mL of RBC Lysis 
buffer for 5 minutes, and the lysis immediately stopped by adding a volume of PBS 
twice the lysis solution. Cell enriched media falcon tubes were spinned at 150G for 
10 minutes and re-suspended. Cellular concentration was counted with Burker 
camera to calculate the exact amount of reagents for magnetic separation needed. 
The 2D2 negative mice pool was used to destroy B-cells master regulators and 
break the membrane to obtain MHC molecules with stimulating cytokines.  
CD4 population of B-cells was extracted from the 2D2 positive mice cell 
suspension. Magnetic columns with nano-sized beads were used (MACS™, 
Myltenyi biotec, DE), because column-free methods require high concentrations of 
labelling reagents with the risking of non-specific labelling of the target cell 
fraction. CD4 population is not stimulated by the nano-sized microbeads and they 
do not overload with the desired cells in the solution.  
The following scheme was adapted from CD4+ T cell isolation kit and the quantities 
were meant for 108 cells (Table 2.1). Upscale was done accordingly with the 
number of cells in the cell suspension. To avoid column clogging, volumes 
containing more than 108 cells were split in more than one column or diluted. 
MACS conjugates antibodies were added to the cell suspension and cells were 
subjected to positive selection with a first eluition. When the columns were 
removed from the magnetic support, the second eluition was collected, enriched in 
CD4+ naïve cells (Fig 2.2., D)  
 
Volumes for 108 cells 
1st addition of MACS Buffer 400µL 
T cell isolation biotin cocktail 100µL 
Incubation on ice for 5’ 
2nd addition of MACS Buffer 300µL 
Anti biotin microbeads 200µL 
Incubation on ice for 10’ 
 
Table 2.1. Volumes of reagents used for CD4+ isolation with MACS columns. Steps are followed 
for each row in sterility under biological hood. 
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Figure 2.2: CD4+ isolation steps, MACS technology (adapted from Grützkau, Radbruch, 2010);  
. Magnetically labelled cells in two steps (A and  B) are retained in the column (C), while 
unlabeled cells flow through. After a washing step, the column is removed from the magnetic field 
of the separator (D), and target cells are eluted from the column. 
 
First, the columns were primed with 3ml of buffer (MACS LS column). As soon as 
the tank was empty, cell suspension enriched with nanobeads coated with  CD4+ 
antibody was applied. The second flow through is enriched in CD4+ T cells, and to 
a better collection and concentration of them, the columns were washed again with 
3 mL of MACS buffer.  
Eluition collected was spinned down at 150G for 10’ and the pellet resuspended in 
fresh clone media. T-cells were counted in the solution to make a suspension of 
4*106 cells/mL. The suspension was cultured at 2*106 cells/mL in coated-6-well 
plates (NUNCLON Delta, corning Thermo Fisher, DE) and incubated for 48 hrs at 
37% with 5% CO2 concentration.   
The single cell suspension from 2D2 negative mice spleens was incubated on ice 
and irradiate at 30Gy with a Cs-137 source, preheated at 225kV, 13mA, 810 times, 
for 7 minutes. The splenocytes were coltured at 107 mL-1 in clone media, to prepare 
a suspension in concentration 2*107 mL-1. A cytokines mix that consisted in mIL-
12 (20ng/mL ) anti CD3 (5µg/mL), anti-IL-4 (40µg/mL) was added, in a volume 
twice the concentration of the harvested cells.  
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Both CD4T+ and irradiated splenocytes were mixed to obtain an homogeneous 
suspension, in ratio 2:1 of volume respectively, and distributed to 6-well plates for 
cell culture. The plates were incubated for 48 hours at 5% CO2; afterwards the wells 
were pooled and an interleukine as polarization factor was added to the suspension, 
hIL-2, at concentration of 4ng/mL. 
The differentiation was monitored for 48 hours, and clone media changed with fresh 
one and/or the colture splitted to avoid clusters. After an initial phase of 
proliferation and blasting, cells reached a plateau.  
At this point, the colture was re-stimulated with anti-CD3 (stock 6.9mg/ml) and 
anti-CD28 (stock 4.33mg/ml) at 2ug/mL, in order to obtain polarized Th17 cells, at 
the concentration of 2*106 mL-1. The latter stimulation factors were added as 
coating on new 6-well plates.  
After an other incubation of 48  hours, viability and differentiation were controlled 
by means of FACS intra and extra-cellular staining. Th17 once polarized express 
both specific surface receptors unlike non stimulated CD4+ population and 
cytokines. The antibody-fluorochrome conjugates were set before the staining and 
the panel with respectives dilution factors is reported in table 2.2 . First step in 
FACS staining is to prepare cells in order to receive fluorescent conjugates. For one 
sample, 100 uL of cell suspension was washed in PBS, then resuspended with fix 
solution. The solution was transfered in a FACS plate and incubated for 30’ at 4°C, 
protected from light.  
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Table 2.2. FACS panel for flow cytometry assay of Th17 cell viability and differentiation. FACS 
buffer is calculated per volume and mixed with diluted antibodies. DF: dilution factor. 
 
For extracellular FACS staining, to avoid interference with other membrane 
receptors, one step was added before adding the conjugates to the sample. The 
amount of cell suspension was pre-treated with an antibody that block low chain 
receptors (FcR) in concentration half the volume of the sample (αFcR-
Ab/CD16CD32, 1:100 in FACS buffer (PBS 1X, in bovine serum albumin 1%). 
The plate was incubated on ice, not exposed to light, for 20’ and it was washed with 
FACS Buffer twice after two spinning cycle at 500G, for 5’. 
For intracellular FACS staining, cells suspension was first permeabilized with a 
series of reagents (transcription factor staining kit FoxP3, for 20’ at 4°C. The cells 
were washed after a centrifugation at 500G for 10’. Cell permeabilization was kept 
with wash buffer PBS + 0.1% NaN3 + 5% fetal bovine serum at each step. 
Immediately after, the antibody cocktail from the FACS designed panel was added 
to the solution. Cells were resuspended in 200uL of fixing reagent after a centrifuge 
at 500G for 10’. 
M
et
h
o
d
 Reagents 
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CD45-AmCyan (BV510) 1/100  CD45-AmCyan (BV510) 1/100  
CD3-APC eFluor780 1/100  CD3-APC eFluor780 1/100  
CD4- alexafluor 700 1/160  CD4- alexafluor 700 1/160  
CD44-alexafluor 647 1/200  CD44-alexafluor 647 1/200  
FACS buffer N/A FACS buffer N/A 
In
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a
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u
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g
 Antibody-conjugate DF    
Il-17 PECy7 1/100    
IFN-g-FITC (AF 488) 1/400    
RORgT BV421 1/100    
Perm/Wash buffer N/A    
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Results from FACS staining are reported in the next section. Once the reference 
measures checked the viability and the differentiation of the cell coltured, incubated 
Th17 plates were pooled and diluted in clone media for intraperitoneal injection. 
The suspension concentration was calculated to obtain 3-5x106 cytokines producing 
cells, per mouse.  
 
2.1.3 MRI acquisition in EAE induced by Th17 cell transfer in mice: Diffusion, T1 
and T2 weighted imaging 
 
To elucidate brain alterations at structural level in the used preclinical model that 
exhibits neuronal and axonal damage across brain sections, diffusion weighted, 3D 
T1 weighted and T2 weighted sequences were chosen for in-vivo and ex-vivo 
experiments. This study focused on the investigation of brain lesion driven by 
immunological inflammation, in which we expected, at the chronic stage myelin 
damage and tissutal alterations at the boundaries of major plaques.  
All the experiments were carried at the CIBM - Centre de Imagerie Biomedicale, a 
facility of - Ecole Federale Politecnique de Lausanne (EFPL campus, CH).  The 
CIBM hosts a 9.4T system (Varian), supported by adjacent animal preparation suite 
for physiological monitoring and surgical interventions, and 14.1 T/26 cm system 
(Magnex Scientific, Oxford, UK) interfaced to a Varian Direct Drive console (Palo 
Alto, CA, USA) equipped with 12-cm inner-diameter actively-shielded gradient set 
with a maximum gradient of 400 mT/m in 120 ls. For the ex vivo study, a total of 
20 C57BLJ6 mice of 8 weeks were used: 10 mice were injected with 200 uL i.p. of 
Th17 pre-coltured cells; 10 mice were assigned as controls and not immunized. 
First, the pilot in-vivo study was conducted to test the feasibility of methods and 
adjust parameters, to achieve the higher number of diffusion coefficients and the 
best resolution in mouse brain. For the in-vivo experiment, five C57BL6J mice 
were scanned at two time points, after one week of acclimatisation in the animal 
facility, the latter at the disease onset. Only two images were acquired in-vivo, i.e. 
T2 maps and DWI for each mouse. EAE score was assessed as reported in table 2.3. 
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Because of the severity of the disease, EAE mice were sacrificed and perfused after 
the second MRI acquisition, then the collected brains were imaged for ex-vivo 
experiments to achieve MRI protocol optimization.  
 
EAE typical signs score 
No disease 0 
Decrease tail tone 1 
Hind limb weakness, partial paralysis 2 
Complete hind limb paralysis 3 
Front and hind limb paralysis 4 
Moribund state 5 
 
EAE atypical signs score 
No disease 0 
Mild balance defects 1 
Severe balance effects that cause spontaneous falling over 2 
Very severe balance defects that prevent walking 3 
Inability to move body weight into a different position 4 
Moribund state 5 
 
EAE combined signs: sum of atypical and typical scores 
 
Body weight score 
Loss of 5-10% 1 
Loss of 10-20% 2 
Loss of >20% 3 
 
Table 2.3 . EAE disease score reference. Because of heterogeneity of symptomatic signs, the 
pathology is checked by combined disease score points. 
 
Acquired images showed low SNR in vivo for both scanners at that time. In order 
to add more b-values in DWI, and T1/T2 mapping, final acquisitions were performed 
only ex-vivo at 9T. 
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2.1.4 EAE in vivo diffusion weighted imaging acquisition 
 
First steps were related to setup correct experimental parameters to optimize SNR 
in brain (volume transmitter/head surface helmet receiver coils) in both scanners.  
Animals were placed inside the scanner under 1.5% isoflurane, maintaining 54 
breath rate per minute and 25 °C body temperature, constantly monitored by small 
animal monitor sensors and a rectal probe. 
In vivo multi‐slice T2 weighted imaging was performed using fast spin echo with 
an effective echo time (TE) of 52 ms, and a repetition time (TR) of 5000 ms,  FOV 
11.2 × 11.2 mm2, data matrix 2562, slice thickness 0.8 mm.  
In vivo diffusion-weighted images consisted in a pulse gradient stimulated echo 
with the following parameters (3DGRE): TR = 4000 ms, TE  = 22 ms, FOV 
11.2 × 11.2 mm2, data matrix 2562, slice thickness 0.8 mm. This pilot study 
explored several b values, with a gradient duration of 4 ms applied along the readout 
direction, in the X axis.  Eight b-values plus no weighted reference were applied, to 
avoid more than 30 minutes of total scan time (0, 250, 320, 510, 754, 830, 900, 
1000), FOV length in read out direction 1.8 cm, FOV length in phase encoding 
directions 1.2 and 1.12 cm, slice thickness of 112, matrix (readout number of points) 
256 x 86 x 64, 2 averages, number of slices 21. 
Representative SNR outcome in T2w images for 14.1 T is reported in Figure 2.3. 
 
Figure 2.3. Representative T2w weighted images of mouse brain with surface coil helmet in-vivo, 
at 9 T (first column) and 14.1T (second column), coronal, axial and sagittal section, hippocampus 
centered. SNR was higher for T1w images, but not suitable for DWI and T2w protocols. 
30 
 
The final experiments were performed using only the  9.4 T scanner, which 
exhibited better SNR (Signal-to-Noise Ratio) in 3 out of 4 sequences for in-vivo 
and ex-vivo imaging. 
 
2.1.5 EAE ex-vivo imaging preparation 
 
Animals were pre-anesthetized with a mixture of ketamine/xylazine before reaching 
the anesthetic depth for surgery. Perfusion consisted in two steps; once thoracotomy 
was performed to expose the heart, blood was washed out with PBS 1X for a total 
volume of 15mL, followed immediately by fixation with PFA 4% in normal saline 
solution. Pressure was maintained constant, using a connected Gilson peristaltic 
pump, pre-set for small rodents perfusions, with 2mL/min flow. 
Mouse heads were dissected in order to remove skull and surrounding structures, 
spleen and the whole spinal cord collected for further reference. All the organs were 
immersed in PFA 4% in phosphate buffer for at least 4 hours, then they were left in 
PBS 1X, pH 7.2.  
After remaining in fixative solution, brains were transferred for a week in sterile 
PBS 1X with 2% sodium azide, to preserve tissue integrity from mould 
contaminations. Immediately before time scan sessions, the specimens were 
transferred to Fomblin Y LVAC 06/6 (perfluoropolyether, Solvay, US), to avoid 
any spurious signals from the solution, and further they were degassed for air 
bubbles removal, to reduce magnetic susceptibility artifacts. The overall MRI 
pipeline is depicted in Fig. 2.4. 
 
Figure2.4. MRI pipeline applied in the experimental model of  EAE induced  by Th17 adoptive 
transfer (A) preliminar in –vivo experiments. B) ex-vivo high resolution experiments. 
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2.1.6 DWI and T1/T2 weighted ex-vivo image acquisition 
 
First, one-dimension pulse sequence was acquired for system calibration. 
Frequency lock and signal were checked before local shimming. After a scout 
image to position the brain correctly, the final protocol was set with the following 
parameters:  
T1w images were acquired by means of 3D MP2RAGE sequence with the 
following setup: TE delay 4 seconds, TR 4 seconds, spoil time 4 sec; matrix size 
(readout number of points) 256 x 64 x 28; slice thickness: 112 um, contiguous; TE 
0.005 sec, TR 4.8 sec, FOV length in phase encode direction 1.2 cm; FOV length 
in read out direction 1.8 cm.  
T2w images were acquired by means of MEMS sequence, at 24 different Echo 
Times (ms) : 8.8, 17.6, 24, 26.4, 35.2, 44, 52.8, 61.6, 70.4, 79.2, 88, 96.8, 105.6, 
114.4, 123.2, 132, 140.8, 149.6, 158.4, 167.2, 176, 184.8, 193.6, 202.4, 211.2; TR 
5.5 ms; Slice thickness 400 um, number of slice 24, matrix size readout number of 
points 256; FOV length in phase encode direction 1.2 cm, FOV length in read out 
direction 1.8 cm. 
Diffusion weighted images consisted in 3DGRE sequence setup: TE 0.04 sec, TR 
0.025, 28 GE cycles, linear encoding, 16 b-values plus no weighted reference (0, 
10, 60, 130, 200, 250, 320, 390, 440, 510, 580, 630, 700, 770, 830, 900, 1000 
s/mm2), 2 averages, number of slices 21, FOV length in read out direction 1.8 cm, 
FOV length in phase encoding directions 1.2 and 1.12 cm, slice thickness of 112, 
matrix (readout number of points) 256 x 86 x 64. 
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2.1.7 DWI and T1/T2 ex-vivo weighted image processing 
 
All acquired in-vivo and ex-vivo images were analysed by means of custom scripts 
in matlab software environment. Metrics extracted were related to mean, parallel 
and perpendicular (i.e. axial and radial diffusivity, respectively) diffusivity. T1 and 
T2 weighted images were processed to obtain corresponding maps. In-vivo maps 
were reported previously as representative images and no further discussed in this 
work. Moreover, noise was corrected for DWI scans by means of B0 map for each 
scanned mouse. For further information, a little overview is reported in the 
appendix, section A. 
DTI matrix was obtained from diffusion weighted images from the three gradient 
directions using custom matlab scripts. Diffusivity parameters, λ1, λ2 and λ3 were 
considered as scalar indices associated to white matter fiber tracts geometry 
(Basser, Pierpaoli, 1998). Calculations were made using the equations reported 
below.  
 
λ1 = 𝑙𝑜𝑛𝑔𝑖𝑡𝑢𝑑𝑖𝑛𝑎𝑙 (𝑎𝑥𝑖𝑎𝑙) 𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑖𝑡𝑦  
(λ2 + λ3)/2 = 𝑟𝑎𝑑𝑖𝑎𝑙 𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑖𝑡𝑦 
(λ1 + λ2 + λ3)/3 = 𝑚𝑒𝑎𝑛 𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑣𝑖𝑡𝑦 
√
1
2
√(λ1 − λ2)2 + (λ1 − λ3)2 + (λ2 − λ3)2
√( λ1
2 +  λ2
2 +  λ3
2)2
= 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑛𝑖𝑠𝑜𝑡𝑟𝑜𝑝𝑦 
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2.1.8 Histology in the EAE induced by Th17 cell transfer  
 
Before ex-vivo imaging, organs were fixed for successive histology. Brain were 
scanned at 9.4 T, at the peak of the inflammatory stage, then processed for 
histological staining.  
After the MRI sessions, brains and other organs were subjected to de-hydration 
process, that consisted in increasing alcohol concentration (EtOH, 50%, 70%, 90%, 
95%) and a latter step in xylene solution twice for a total time of 1 hour. Samples 
were embedded in paraffin by means of a warmed paraffin bead tray, with a cooling 
pad module (Leica tissue embedder, DE). Spinal cord, brain sections, as well as 
liver and spleen for control were placed in the same tray for each mouse, following 
a previously described method (Steinbach and Merkler, 2009). Hardened paraffin 
blocks were cut in coronal sections 5µm thick, using a rotative microtome (Leica 
Biosystem). Serial slides were re-hydrated by means of decreasing EtOH 
concentrations until their immersion in distilled water. Number of lesions was 
detected using hematoxylin, counterstained with eosin (HE). Myelin distribution 
and distruption was assessed with Luxol Fast Blue (LFB), dissolved in EtOH, 
counterstained with periodic acid Schiff. Cell nuclei were visualized with 
hematoxylin; axons and nervous fibers by means of silver nitrate impregnation, 
(Bieschlowski, 1903). After dehydration, all the slides were mounted in Entellan 
(Merck Millipore, Germany).  
 
Antibody Primary antibody Antigen retrieval Secondary antibody 
T-cells CD3 Citrate (pH = 6) Biotin anti-rat 
T-cells CD4 Citrate Biotin anti-rat 
Oligodendroglia Oligo2 Citrate  
Activated macrophages Mac3 Citrate Biotin anti-rat 
 
Table 2.6. antibodies used for Immunohistochemistry (IHC) and inflammatory evaluation 
 
The severity of the disease in EAE may vary during the disease course. 
Inflammation at onset stage is more pronounced. In the model used, the peak of 
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CNS damage is dependent of Th17 viability and occurs between the 13th and 15th 
day post i.p. injection.  
Quantitative assessments of the observed lesions were made with different 
immunohistochemistry staining, with a protocol adapted for mouse tissues, using 
the primary antibodies panel showed in table 2.6.  
Nerve fibers were observed by means of Bielschowsky’s silver staining.  
Inflammatory foci (IF)  in n spinal cord section and n brain slices were counted in 
HE slides. The inflammatory index was calculated as follows: 
𝐼𝐹 𝑖𝑛𝑑𝑒𝑥 =  
∑ 𝐼𝐹𝑛𝑖
𝑛
  
Measure of demyelinated areas was performed on LFB/PAS slides; white matter 
(WM) area was also measured. The degree of de-myelinization was expressed 
according to the following formula, where n is the number of portions analyzed 
(spinal cord or medulla sections mostly): 
𝑑𝑒𝑚𝑦𝑒𝑙𝑖𝑛𝑎𝑡𝑖𝑜𝑛 𝑑𝑒𝑔𝑟𝑒𝑒 =
 ∑
𝐷𝑒𝑚𝑦𝑒𝑙𝑖𝑛𝑎𝑡𝑒𝑑 𝑎𝑟𝑒𝑎
𝑊𝑀 𝑎𝑟𝑒𝑎
𝑛
𝑖
𝑛
 
T-cells, macrophages and Oligodendroglia were manually counted over the whole 
brain area in each slide; the infiltration density was calculated using the equation 
reported below:  
𝑇 𝑐𝑒𝑙𝑙𝑠
𝑚𝑚2
=
∑
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑇 𝑐𝑒𝑙𝑙𝑠 (𝑚𝑎𝑐𝑟𝑜𝑝ℎ𝑎𝑔𝑒𝑠)
𝑊𝑀 𝑎𝑟𝑒𝑎
𝑛
𝑖
𝑛
 
 
Axonal density was also calculated for the spinal cords of EAE versus healthy 
controls: 
𝑎𝑥𝑜𝑛𝑎𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑥𝑜𝑛𝑠
𝑎𝑛𝑎𝑙𝑦𝑧𝑒𝑑 𝑎𝑟𝑒𝑎
 
 
𝑎𝑥𝑜𝑛𝑎𝑙/𝑓𝑖𝑏𝑒𝑟 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑜𝑝𝑡𝑖𝑐𝑎𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑎𝑛𝑎𝑙𝑦𝑧𝑒𝑑 𝑎𝑟𝑒𝑎
 
 
Axons can be easily counted in spinal cord cross-sections, but in the 
medullar/cerebellar region they are packed in nerve fibers. In this case, the 
cerebellar-medullar portions of the brain were evaluated by optical density obtained 
from blackish silver impregnation, using ImageJ software. 
35 
 
2.2 EAE induction by MOG injection and Ptx sensitization 
 
After local animal care committee reviews about the protocols aforementioned, all 
research involving animals were carried out following the directive 86/609/EEC 
and dl 116/01/92 Italian legislative decree. All animals involved in these studies 
were stored in animal facility with food and water ad libitum, conventional animal 
facility. 
Immunization was induced in 10 C57Bl/6 mice of 6–8 weeks old, by means of 
subcutaneous injection of MOG33–35 peptide in complete Freund’s adjuvant with 
Mycobacterium Tuberculosis, 300 μg and 0.8 mg/ml, respectively. Mice were also 
injected intravenously (i.v.) with pertussis toxin (40 ng) at the day of immunization 
and after 48 hours, following a previously reported method (Costantin, 1999). Score 
was assessed with the criteria reported in table 2.3, while mice that exhibited 
atypical signs (paraesthesia, lack of coordination) were excluded from the study. 
 
EAE disease signs score 
No disease 0 
No tail tone 1 
Mild hind limb weakness 1.5 
Hind limb weakness, partial paralysis 2 
Complete hind limb paralysis 2.5 
Front and hind limb paralysis 3 
Moribund state 4 
 
Table 2.3 EAE induced by active MOG score on C57BLJ6 mice. 
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2.3 SOD development and score assessment 
 
Wild type (WT) B6SJL strain (Jackson Laboratories, ME, USA) were crossed with 
mouse line carrying the mutant SOD1 human gene, B6SJL-
Tg(SOD1*G93A)1Gur/J GH1. The gene is driven by human promoter sequence of 
superoxide dismutase 1 and the mouse was designed as hemizygous B6SJL.SOD1-
G93A.  
Transgenic progeny was identified by polymerase chain reaction targeting the 
SOD1(93A) gene, as defined from jax allele datasheet. Disease development was 
longer than high copy number SOD1 mice and similar to previously published data 
(Henriques, Pitzer et al, 2010).  
All mice were trained weekly to motor test, after the 50th day from birth. Motor 
coordination assessment included scoring signs of muscular deficit, paw grip, and 
rotarod task execution. Also body weight was measured to determine the correct 
timing of disease stages to be considered for rsfMRI acquisitions.  
Motor deficit signs were evaluated following the score scale in tab. 2.4. Measures 
were reported by Bonafede R. and Scambi I, from Mariotti research group at 
Department of Neurological Sciences and Movement, University of Verona.   
Onset symptoms were assessed in presence of combined body tremor, lack of hind 
limb extension reflex as well as three consecutive failures in motor tests. End stage 
symptoms included exacerbated signs of motor weakness and severe body 
paralysis.  
At the end stage, after MRI acquisitions mice were sacrificed as they reached the 
humane endpoint. Objective measurements were performed twice weekly by means 
of paw grip extension test (PGE) and rotarod test. Previously reported protocols 
were used to assess clinical score and conduct PGE and rotarod test correctly 
(Gurney et al., 2004; Miana-Mena et al, 2005; Weydt et al, 2003). PGE test 
consisted by placing each mouse onto a metal grid. The grid was quickly turned up 
and down and the latency until the mouse let go with both hindlimbs was timed. 
Two attempts per mouse, with a cut-off time of 120s, were given to hold onto the 
inverted grid. Time spent in the rotating rod was measured also, with a cut-off of 
180s. Test consisted in placing the mouse in the rotarod, increasing the rotation 
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speed until 16 rpm. The time spent in the rod until fall was recorded, two trials per 
mouse. 
 
Clinical signs Score 
Normal 4 
Hindlimb tremors when mice is suspended by the tail 3 
Normal gait disturbances and abnormalities 2 
Hindlimb dragging 1 
Inability to right after 30 seconds 0 
Table 2.4 Disease score scale for SOD1 mice 
 
 
2.4 RsfMRI acquisition in the MOG-induced EAE and in the SOD93A experimental 
models.  
 
Preliminary experiments were performed in a group of n=10 C57Bl/6 female mice, 
never immunized, to validate the rsfMRI protocol and the processing pipeline.   
Second pool of rsfMRI experiments involved two different neuropathological 
disease models: 
i) EAE MOG/Ptx mice (n=10) and not immunized mice age-matched as controls 
(n=10). All mice were acquired at two time points: first was at 1st day post 
immunization, while the second was at 20 days. EAE were followed until the 26th 
day to assess the disease progression. 
ii) SOD-1 (G93A) transgenic mice (n= 11) and n = 10 age-matched wild type (WT) 
(B6SJL) mice were used as controls (WT). All mice were scanned twice. Two 
acquisitions were performed, first at the disease onset and second at the end stage 
of the disease, in SOD and WT respectively. For SOD(G93A) mice, rsfMRI 
experiments were performed at first rotarod test failure, as reported in literature 
(Luh, Das and Bertolotti, 2018), and at severe paralysis (about 90 and 120 days 
from birth, respectively).  All experiment were carried at University of Verona.  
RsfMRI scanner setup and in-vivo pipeline consisted in a scout image, a single shot 
EPI sequence for motion correction, the EPI functional image and a T2w high-
resolution image (fig.2.5).  A total number of 41 mice were used for this method. 
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Figure 2.5 Timeline of rsfMRI experiment at 4.7T. Anaesthesia regime was modulated to create 
less interference with cerebral blood volume. EPI sv: single shot, tilted orientation, one single 
volume; EPI 300v: 300 volumes. 
 
In vivo acquisitions were performed on a Biospec Tomograph operating at 4.7T, 
equipped with AVANCE II electronics (Bruker, Germany), available at Centro 
Piattaforme Tecnologiche ( University of Verona, Italy). The capability of the self-
shielded gradient was 40G/cm in intensity (BGA9, Bruker, Germany). A double 
coil configuration with a 7.2 cm i.d. bird cage volume coil  and a helmet-shaped 
surface coil used as RF transmitter and receiver respectively.  
The anaesthesia regimen  was adjusted accordingly to previously reported studies 
(Shah, 2016).  Mice were anaesthetized with 2 - 2.5% Isoflurane (in a mixture of 
O2/N2 50/50%) in a plexiglas induction chamber. Once the mice were positioned 
into the scanner, transcutaneous pCO2 sensor and breath pads were added to 
monitor the physiological parameters during the experiments. Body temperature 
was maintained at 37–38°C through a warm water circuit embedded in the animal 
holder (Bruker Biospin GmbH, Ettlingen, Germany).  
Instrument preparation and connected devices are depicted in Fig 2.6. Gas 
anesthesia was maintained inside the scanner at 2%, with a maximum of 2.5 %, 
accordingly to mice weight, and administered via a facemask (Fluovac, Harvard 
Apparatus) connected to a coaxial circuit. To avoid motions artifacts, the head was 
immobilized by means of ear bars, and the mouth fixed with a dedicated bite bar. 
Before acquisition of rsfMRI images, mice received an i.p. bolus injection of 0.3 
mg/kg of medetomidine. Immediately after, gaseous anesthesia was reduced to 
0.3%, with vehicles gases O2/N2 at 30/70%, to increase oxygen inhalation and avoid 
low cardiac rate due to isoflurane interference with medetomidine. The pCO2 
39 
 
remained within the physiological range during the overall imaging timeline (34 – 
40 mmHg). Mice that exhibited higher pCO2 values, during the EPI acquisition, 
were excluded from the study. 
 
Figure 2.6. Animal preparation for imaging acquisition (A); I) control gating module coupled to 
laptop monitor of physiological parameters (I), pCO2 sensor (II), thermostatic warm circuit tubes 
connections (III) and anesthesia tubes (IV). Animal bed is connected to the respective systems (B); 
after placing the animal with each sensor (C), head helmet coil (SC) is ready to be positioned 
above the two plastic guides (D).  
 
A scout FLASH image was acquired to ensure correct brain positioning. Magnetic 
field inhomogeneity was optimized with a modified shimming Bruker protocol to 
cover selected FOV. RsfMRI method was started first, and it consisted in two EPI 
sequences: one for FSL topup tool correction and one with the same parameters 
(except for readout direction) for BOLD imaging. Under medetomidine bolus 
effect, images were acquired by means of EPI sequence set as follows, TR=1200ms, 
TE=7.6ms, 0.313x0.313 mm in-plane resolution, 20 slices 1mm thick, 300 
volumes, readout l-r. The last image of the protocol was an anatomical T2w RARE 
sequence with the following parameters: TR=5760ms, TE=76ms, 0.156x0.156 mm 
in-plane resolution, 20 slices of 1mm of thickness. Once the imaging pipeline 
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finished, a s.c. injection of the antidote (atipamezole 0.1 mg/kg) was administered 
to counteract the previously administered s.c. anaesthesia and to permit faster 
recovery of the animals. In order to investigate the progression of the pathology and 
in agreement with  previously conducted fMRI experiments on an EAE rat model 
(Tambalo et al., 2015), and ALS SOD1(G93A) imaging (Bontempi, 2017), 
functional MRI experiments were conducted at two time points along the time 
course of the disease.  
 
2.4.1 RsfMRI processing  
 
All echo planar images were collected at the end of both studies in EAE and SOD.  
To identify functional connectivity networks in mice, FSL suite was used, with 
adapted mouse brain atlas for 4.7. T resolution.  Timecourses were extracted 
focusing on low frequency signal fluctuations. Movement artifacts were removed 
from each scan by means of blind and indipendent inspection. Cerebellum and 
medulla were excluded a priori from the analysis, as well the olfactory tract and 
ventricles, focusing on functional cortex parcellation. Brains scans were masked, 
spatially smoothed, temporally filtered and normalized to be further processed for 
independent component analysis (ICA). Analysis with FSL was only on healthy 
mice preliminary pool. 
For EAE and SOD study, all EPI scans were processed into  SPM and AFNI (Penny, 
Friston et al., 2006). A warped mouse reference brain atlas (Dorr, 2008) was used, 
re-scaled to the resolution of rsfMRI scans. Areas with higher susceptibility 
corresponding to vessels and cerebral cavities filled with cerebrospinal fluid (i.e. 
cerebral acqueduct, ventricular system), as well as the first 4 volumes acquired in 
the EPI scans were removed from the analysis. Each EPI scan was registered to its 
anatomical image, and put in the same space. EPI were normalized, masked and 
smoothed before BOLD values extraction per each mouse. ROI-based timecourses 
were extracted by means of MarsBAR (Brett, Anton et al., 2002).  
Brain mouse atlas was parcellated into sub-regions that are listed in Table 2.7 
.  
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Table 2.7 Table of brain regions filled in the FSL toolbox and SPM-GiftICA pipeline. These 
regions were segmented and used for BOLD signal extraction and they derive from resampled 
reference Dorr mouse brain atlas, +: regions added from previous functional brain networks, 
reported in previous described literature. 
 
A) Mouse brain regions (Amg – IP) A) Mouse brain regions (lo – vgtx) 
Abbreviation Long nomenclature Abbreviation Long nomenclature 
Amg Amygdala lo Lateral olfactory tract 
abv Arbor vitae of cerebellum LSC Lateral septal complex/nucleus 
aca Anterior part commissure MB Midbrain 
Acb Nucleus accumbens mlf Medial longitudinal fasciculus 
acp Posterior part commissure MC+ Motor cortex 
Au+ Auditory cortex MO  Medulla oblongata 
BF Basal Forebrain MSC Medial septum 
BNST Bed nucleus of stria terminalis mt Mammillothalamic tract 
cb Cerebellum OL Occipital lobe 
Cg Cingulate anterior Olf Olfactory bulb 
cp Cerebral peduncle opt Optical tract 
Cpu Caudate putamen PAG Periacqueductal grey 
Cu Cuneate nucleus Pas Parasubiculum 
DG Dentate gyrus Pir Piriform cortex 
Enth Enthorinal region Pn Pontine nucleus 
fi fimbria Pons Pons 
Fro Frontal lobe Ptl Parieto temporal lobe 
Fs Fundus of striatum RC Rhinal cortex 
fx fornix RS Retrosplenial cortex 
GP Globus Pallidus SC Superior colliculus 
GrDG+ Granular layer DG sm Stria medullaris 
hbc Habenular commissure SOIC Superior olivary complex 
Hi Hippocampus Ss+ Somatosensory cortex 
Hy Hypotalamus st Stria terminalis 
IC Inferior colliculus Th Thalamus 
IO Inferior olivary complex Tu Olfactory tubercle 
IP Inferior cerebellar peduncle vgtx ventral tegmental area 
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2.5.2 RsfMRI statistical analysis 
 
FSL’s MELODIC tool was used after EPI images preprocessing in the preliminary 
study on healthy mice. In order to identify  ICAs (by means of Independent 
component analysis) related to brain sub-networks, this was the first approach on 
preliminary dataset with healthy mice. Within group differences were analyzed by 
means of within (dual regression) and between (FSLNETS) network comparison. 
Moreover the pre-processed time series were input into MELODIC and used for a 
region-by-region analysis. This method was used to determine the feasibility of 
functional networks discovery at 4.7T. Analysis pipeline is shown below (fig. 2.7). 
 
 
Figure 2.7. Analysis steps in software environment after rsfMRI acquisition. ICA 
independent component analysis. Red box shows input of statistical analysis. 
 
The second approach, on EAE and SOD datasets, was with SPM/GIFTICA 
toolboxes, run in Matlab software.   
A matrix with size of 54x54 correlation coefficients is therefore obtained for EAE, 
SOD and their respective control mice. Only positive Pearson correlations values, 
in selected brain region from 54 segmented areas, were accepted as significant. 
Statistical analysis focused on different functional/resting state networks as 
previously described in literature (Gozzi, 2016; Grandjean, 2020). 
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Once obtained correlation values, to compare which regions in brain differ between 
groups, multiple comparisons tests was performed, applying false discovery rate 
correction. Only regions with p values below 0.05 were accepted as significant.  
To observe activated functional networks in these experiments, also  Independent 
Component Analysis (ICA) approach was used, similar to the end of FSL pipeline 
used for the pilot study (Group ICA). Independent component analysis was 
performed by means of another software, with the same algorithm, named GiftICA 
(Bajic, 2017), inside matlab environment, after region-wise correlation analysis. 
GifICA is based on ICASSO algorithm; all pre processed scans were non-spherical 
extracted, to proceed with analysis between each group. This choice was more 
flexible in independent components selection (ICs), in terms of thresholding, 
number of components and dual regression, as previously stated in rodent brain 
networks research (Bajic, 2017). Resulted ICs were per each group, that means 
EAE, SOD at onset, SOD at end stage and their respective controls. 
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3. Results 
3.1. Development of Experimental Autoimmune Encephalomyelitis by adoptive 
transfer and ex-vivo neuroimaging correlates. 
3.1.1  Phenotyping of 2D2 donor mice for Th17 cell culture 
Before proceeding to lymphocytes extraction and cell differentiation to obtain Th17 
population in vitro, donors were selected by means of FACS phenotyping of CD 
cells. Mouse colony started from 2D2 transgenic (Tg) mice, as described in the 
material and methods section 2.1, crossed with C57BJ6 strain. The 2D2 transgenic 
strain is commercially available and previously reported (Bettelli, 2003). 2D2 Tg 
mice express, on their T-cells, rearranged Vα3.2 and Vβ11 chains. These chains are 
on receptor surface (TCR) and specific to myelin oligodendrocyte glycoprotein 
(MOG). That means that circulating CD cells in 2D2 mice have on their surface 
these chains that can be detected by flow cytometry assay.  
2D2 Tg line was used to to start colture of T naïve cells, following spleen and 
lymphnodes harvest from mice. First, blood samples were collected from jaw vein 
and centrifuged to prepare stainings with APC, PE conjugated fluorophores to 
specific antibodies.  
Positive fluorescence for CD4 cells and Vα3.2 in the sample, gated for values above 
103 arbitrary units (a.u.), indicated hemizygote 2D2 mice that can be used to harvest 
lymphocytes and splenocytes and start a Th17 colture in vitro (Fig.3.1).    
Figure 3.1 SSC/FCS plot. V3α3.2/CD4 plot are shown for two representative mice genotyped. The 
double positive population for CD4 and V3α.2 staining confirms 2D2 positive Tg mice (right 
panel). Arbitrary units in logarithmic scale. 
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Also cell viability and surface markers in 2D2 mice lymphocytes after cell 
collection, before in-vitro stimulation were assessed. CD4+ cells had higher 
expression as number of events in TCRb, IL-17 and RORγT. Markers of functional 
Th17 cells are IL-17, RORγT, that were identified again by FACS, using the 
reference gating reported in the aforementioned figure. 
 
Figure 3.2 Immune cells were isolated and characterized by means of  FACS stainings. 
Populations of CD4 (x axis) in the sample expressed cytokine IL-17 (A), surface receptor tcr (B). 
Also nuclear receptor RORgT is present in the sample (C) and INFγ (D). antibody conjugates are 
in y-axis and expressed as number of recorded events. Arbitrary units in logarithmic scale. 
The correct in-vitro differentiation of CD4 into subtype Th17 was assessed with 
intra-cellular and membrane staining at the last step of in vitro culture, before 
concentration adjustment for cell injection. Th17 expression markers were 
consistent as previously reported in literature (Jaeger et al, 2009). 
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3.1.2 EAE development: clinical signs and disease score 
Mice were immunized by Th17 cell i.p. injection and observed until the peak of the 
disease. Immunized mice developed neurological signs of EAE between the 10th 
and 13th day after Th17 injection. Weight was measured each day at the same hour 
for all cages, until sacrifice. Score was assessed using as reference an approved 
panel by veterinary committee, reported previously in Material and Methods, 
section 2.4.1. EAE mice exihibited typical and atypical clinical scores, as well as 
weight loss at the peak of the disease (Fig. 3.3). Atypical score included also mouth 
paralysis, asymmetrical ataxia, loss of spatial coordination. In particular, slight 
shaking were noticed before the 10th day of observation for some mice; moreover, 
limp tail and hind limb paralysis was not visible for all of them. EAE induced by 
Th17 cells injection had a sudden onset with ascend paralysis. Changes in gait 
balancing and posture, with the impossibility of coordinated motion, i.e walk in a 
right direction across the space, were classified as atypical signs. 
 
Figure 3.3. EAE mean group weight loss and scores at different time points after induction. All 
grades were averaged for 10 mice that were followed from the day of Th17 cell injection (d0). 
SEM is reported. Two mice were sacrificed at the 13th day due to high weight loss (below the 10% 
of their weight before immunization). 
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3.1.3 MRI scanner choice for ex-vivo imaging pilot study results. 
First pilot study was conducted in vivo with five mice that were immunized as 
described in section 2. This preliminary step was made in order to choice the best 
experimental conditions for further studies. Immediately after the disease onset, 
EAE mice were subjected to optimized protocol for T1w, T2w and DW imaging by 
using the two available scanners operating at 9 and 14.1 T, respectively.  
These acquisitions were performed at different TE, TR and b values for each 
scanner (14.1 and 9 T) both in-vivo and ex-vivo. Careful comparison between 
signal to noise ratio (SNR) obtained by the two scanners revealed that T1w images 
acquired at 14.1 T had better SNR than T1w images acquired at 9.T. However, the 
SNR in both T2w and DW images was better at 9 T than at 14.1 T (data not included 
in this work).  Ex-vivo imaging maps for both scanner is reported in figure 3.4. 
Considering that the aim of the study was to test the specificity of DW metrics in 
detecting lesions in EAE model, the study switched to ex-vivo imaging. DWI needs 
high space resolution with a consequent requirement of long acquisition times. Also 
the availability of scanner-time in the facility was taken in account, thus a good 
compromise was found in using the 9T scanner instead of the 14.1T one.  
 
Figure 3.4 Representative maps of DW metrics obtained in ex vivo EAE mice brain, scanned at 9T 
and 14.1 T, same slice selection. Higher magnetic field showed dishomogeneities visible in the 
maps obtained (red arrow, lower part of the brain). Also, tensor trace map has poorer resolution in 
the three space directions. 
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3.1.4 Ex vivo MRI metrics in the EAE experimental model 
A first raw inspection was made after computation of T1 and T2 times, FA, AD, 
RD and MD values. Huge ROIs were measured by splitting the cerebellar-medullar 
area from the brainstem-cortex one (Fig. 3.5, 3.6). Mean FA and AD were 
significantly different in the cerebellar  and medullar regions compared to whole 
brain after unpaired t test.  
 
 
Figure 3.5. Mean Diffusion metrics in the whole brain, whole cerebellum and medullar area MRI 
slices (Cereb+Med) ± SEM. Values are from averaged mice in the two groups of the study. 
Significativity is shown in bars  (* = p value < 0.05). 
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Figure 3.6. T1 and T2 times expressed in ms ± SEM, in the whole brain, whole cerebellum and 
medullar area MRI slices (Cereb+Med) ± SEM. Values are from averaged mice in the two groups 
of the study. Significativity is shown in bars, with p = 0.1 (p value < 0.05 was accepted as 
significant  
In particular, we addressed the question if ex-vivo gray and white matter, as well as 
the specific lesion area found in histological microphotographs had changed in the 
pathology. ROI tracing was carefully done using an high resolution atlas of mouse 
brain from Allen Brain Institute (Sunkin, 2013; available at https://mouse.brain-
map.org). Histological inspection of brain slices showed where the lesions where 
located, i.e. in the brainstem, medulla and cerebellar regions (fig 3.7). To further 
investigate how these metrics changed in EAE mouse brain, FA, AD, RD, MD, T1 
and T2 values were extracted by manually drawn ROIs from ex vivo images in the 
EAE and CNT groups (Fig.3.8). 
 
Figure 3.7. T1w and T2w images compared to respective histology, one EAE mouse from the 
experimental group; bregma -4.20 (1st row),-5.60 (2nd row). HE staining. Lesion likely location is 
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indicated in MRI images with arrows, while in HE microphotographs asterisk are at the top of the 
overall area in which lesion is visibile. 
 
Figure 3.8 Diffusion metrics from ex-vivo acquired images.  Fractional anisotropy, FA, Mean 
Diffusivity, MD, Radial diffusivity RD, Axial diffusivity AD, apparent diffusion coefficient ADC, 
T1 and T2 values extracted (with SD).  Maps of representative mouse, one per per group are 
flanking the graphs obtained, in two different positions. Measurements are enlightened in the first 
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panel (left, high) in the FA maps. Ctx=Cortex, Cc= Corpus Callosum, MO= medulla Oblungata , 
MO(l) = lesion area in the medulla oblongata, abv = arbor vitae of cerebellum, Cb = cerebellum. 
Significativity is reported as p-value  < 0.02 ( * and thick horizontal bars). 
Statistical significant alterations were detected in T1 (limited to MO(l)) and in T2 
(in Ctx, CC MO(l) Cb, and abv). As expected a general trend toward an increase 
in T2 was observed (Fig. 3.9).  
 
 
Figure 3.9. T1/T2 metrics from ex-vivo acquired images.  T1 and T2 values extracted from T1 and 
T2 weighted images in ms (with SD).  Maps of representative mouse, one per per group, are 
flanking the graphs obtained (EAE and CTRL idem), in two different positions. Measurements are 
enlightened in the first panel (left, high) in the T1 maps (coloured boxes). Ctx=Cortex, Cc= 
Corpus Callosum, MO= medulla Oblungata , MO(l) = lesion area in the medulla oblongata, abv = 
arbor vitae of cerebellum, Cb = cerebellum. Significativity is reported (*) p-value was accepted 
below 0.05). 
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3.1.5 Preliminary DTI results 
Representative diffusion fiber direction maps in CNT and EAE ex-vivo mice are 
reported in Figure 3.15, serial slices from DWI. At qualitative visual inspection, 
tensor imaging did not show evident visual changes in fiber connectivity for all 
EAE involved. Anatomical regions where the lesion was observed by histology 
have different RGB maps, but a tractography approach would highlight possible 
differences in vivo.  
 
Fig.3.15. Ex-vivo diffusion fiber direction maps of two representative mice, healthy (A) and EAE 
(B), respectively. Color codes are red = FA • cos α; green = FA • cos β 
blue = FA • cos γ.  
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3.1.6 Ex vivo MRI and  histological findings in the EAE model by Th17 adoptive 
transfer 
Brain lesions in EAE mice after MRI ex-vivo study were qualitatively evaluated by 
means of H&E staining and compared with T1w and T2w MRI scans (Tab 3.1, Fig. 
3.8). Lesions were clearly detectable in HE slices.  
The localization of lesions determined in histology was therefore used to identify 
alterations in raw MR images. An additional criterion for lesion detection was the 
non-simmetrical occurrence of inflammatory foci in the brain. Results of visual 
inspection of H&E histology and T1w/T2w MR images are reported in Table 3.1. 
Representative T1w and T2w images and their corresponding histological slices are 
reported in Fig. 3.8 where lesions are outlined by red dotted lines.  
 
 
Table 3.1 First inspection of lesions in EAE mice from ex-vivo study in HE stainings. Last 
assigned score is reported A atypical, T typical, as well as combined per mice, before perfusion 
procedure. Presence of contrast variation (+) or not (-) was assessed by visual observation at the 
same position of histological sections. Each mouse in Switzerland has an identification number. 
 
Lesions occurred mostly at the medullar region, as well as cerebellar arbor vitae 
and tissue, associated with demyelinization and nerve fiber distruption at the same 
# mouse score combined # lesions Location T1w  T2w  
E4109 1T, 2A 2 5,11,2 Cb, MO, Optic tract + - 
E4110 2T,3A 3 3,4 MO, Cb + + 
E4111 1T,3A 3 13,15,2 Midbrain, MO, cb + + 
E4112 0T,3A 3 2,2,7,2 Optic tract, abv, cb, MO + + 
E4113 3T,2A 3 2,5 Optic tract, medulla - - 
E4114 2A,1T 2 2 MO - - 
E4115 2T,3A 3 2, 3, 4, 2 Cb, MO, cort.spinal tract, 
abv 
+ + 
E4116 3T,2A 3 3, 6,4 Cb,MO, cereb peduncle + - 
E4117 4T,1A 4 1,3,2 MO, cb, optic tract + - 
E4118 2T, 2A 2 1, 10, 1 3rd V area, MO, abv - - 
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location. Macrophages, CD3 and CD4 cells were present also in the peri-lesion 
areas (fig 3.11).  
Oligo2 stained slides were also visually inspected, but there was no evident change 
in distribution of the expressed marker related to brain lesions at glance, with lower 
magnification used (images not reported).  
Oligo2 expression decreased in spinal cord, and quantitatively its density changed 
between groups both in the brain and spinal cord segments. In the spinal cord, 
axonal loss, swelling and myelin loss was more evident across different sections 
(see Fig. 3.13). 
 
Figure 3.11 IHC of medullar lesion at macroscale, scale bar 500um, bregma -6.56. 
Fiber density loss in each position was visible at lowest magnification as reduction 
of silver impregnation area (Fig. 3.12). At higher magnification, it was  possible to 
detect axonal loss more pronounced in peri-lesion areas (Fig. 3.12). 
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Figure 3.12. Magnified area proximal to lesion, LFB/Bieshlowski stainings bregma -6.24. sp5 = 
spinal trigeminal tract; icp = inferior cerebellar peduncle (proximity of the rubrospinal tract and 
the 4th ventricle), scale bar 200um. 
Cells were manually counted to assess the degree of inflammation in the brain as 
inflammation density (Fig. 3.13). Two-tailed Wilcoxon unpaired t test was 
performed to find differences in collected brain histologies, between EAE and 
healthy mice. 
 
Figure 3.12 Unpaired t-test resulted in significant differences between different inflammatory cells 
outcomes in the whole brain sections. Infiltrates were found mostly at medullar and cerebellar 
level. P values under 0.05 were accepted as significant (*) 
De-myelinization was more visible at the spinal cord level, enriched in neurons, by 
means of loss of luxol blue impregnation to lipids (Fig.3.13).  
56 
 
 
Figure 3.13 spinal cord segments for each position with two different stainings, Bieschlowski (A) 
and  LFB/PAS (B). Scale bar are 100 and 200um, respectively. Section are reported from top to 
bottom in column, in the following order: cervical – lumbar – thoracic – filum terminale. 
 
Silver staining indicated in brain areas a diminished fiber thickness, suggesting this 
disruption is consequence of inflammatory processes evoked by macrophages. 
Cells were manually counted to assess the degree of axonal loss in in the spinal cord 
also (fig. 3.14). 
 
Figure 3.14. Spinal cord portion of an EAE (left) mouse vs CNT (right), Bieschlowski staining. 
Axonal density was calculated for each collected segment (c = cervical, t = thoracic, l = lumbar). 
Scale bar 100um. 
Optical density (OD) values were obtained by means of color deconvolution. 
Original image file format from the slide scanner was first converted in RGB color 
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type, then to 8-bit grayscale. Vector values (R,G,B) were set as follows: for 
Bieschlowski staining: v1 = (0.384,0.558,0.734); v2 = (0.304,0.487,0.818); v3 = 
(0.551, 0.555, 0.623); for Luxol Fast Blue-Period Acid Shift-Eosin v1= (0.583, 
0.553, 0.595) v2=(0.648,0.626,0.431), v3 = (0.851,0.449,0.271). Visual results are 
reported in Figure 3.14, A, followed by calculated OD (Fig. 3.14.B). Myelin 
staining had a p-value < 0.05, while fiber staining had a p-value below the 
significance threshold set, only in the corpus callosum and filum terminale regions. 
 
 
Fig.3.15. A) RGB image conversion and deconvolution for double stainings procedures in three 
vector components. For a healthy subject, silver staining is shown in the 1st row, while LFB/PAS 
in the 2nd one, contiguous slices of 5um thickness. B) Mean LFB and AgNO3 optical density (OD) 
comparison across brain areas. Hipp, thalamic tract: whole myelin OD area at hippocampal level 
and thalamus. Legend: cereb_medulla is whole OD value for the slice at the posterior part of the 
brain containing both cerebellar area and medulla; a.u.arbitrary units, suppongo, cerebellum, 
medulla, sc = spinal cord segments for filum terminale, c = cervical, l = lumbar and t = thoracic. P 
value significativity is reported (** = 0.02, * = 0.05) 
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The overall optical density (OD) measured did not show statistically relevant 
differences, while relative axonal density in the spinal cord segments differed 
between groups. Macrophages were present in the spinal cord segments, in the 
lesions, while a decrease in Oligo2 density is spreaded all over each section in EAE 
mice (Fig. 3.16). Also CD3 and CD4 cells were found in the lesions, but not all the 
inflammatory cells are simultaneously present in all the lesions inspected by 
histology. Presence of axonal degeneration is associated to de-myelinization and 
macrophages infiltrates.  
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Figure 3.14 Immunohistochemistry of different spinal cord segments in two mice, one EAE (panel 
A) and one healthy (CNT) (panel B). Section are reported from top to bottom in column, in the 
following order: cervical – lumbar – thoracic – filum terminale. 
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3.2 RsfMRI results 
3.2.1 Effect of combined anesthesia regimen on the physiological parameters under 
imaging acquisitions 
Some preliminary considerations have to be taken in account, before proceeding to 
the discussion of results for each study. Because BOLD signal is dependent from 
cerebral blood volume, physiological parameters on mice were carefully monitored 
during the acquisition protocol. Different anaesthetics tests in rsfMRI experiment 
showed different outcomes in acquiring BOLD signal. Concentrations above 2.5%  
isoflurane decreased BOLD signal detection in rodents, and homotopic functional 
correlations in mouse brain (Bukhari and Rudin, 2018). Moreover, functional 
connectivity is compromised with other anaesthetics such urethane and chloral 
hydrate (Xie, Chung et al., 2019) because of their side effects. Medetomidine 
combination with low isoflurane concentration resulted more effective to maintain 
brain connectivity at experimental “rest” condition (Shah et al, 2003). Breath rate 
per minute was monitored and compared qualitatively across groups. Anaesthesia 
regime had a double effect: medetomidine lowers the cardiac rate if combined with 
isoflurane, with consequent decrease of body temperature. The first drop in 
temperature is caused by isoflurane inhalation, the second one because of the s.c. 
bolus. A mean measurement with rectal probe is reported in figure Fig. 3.2.1). 
Thermal water circuit linked to scanner animal bed was set at 50°.  
 
Figure 3.2.1 Temperature drop expressed in difference measured.  Data sampling was in minutes 
(m), from rectal probe continuous monitoring. A) temperature starting drop from animal 
preparation with s.c. injection of medetomidine at 1.5% isoflurane. B) second temperature drop 
after scanner placement, effect of medetomidine, at 0.4% isoflurane.  
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Other relevant physiological parameters, namely the partial pressure of CO2 in 
blood, respiratory and cardiac rates were continuously monitored during 
acquisition. Experiments in which such parameters were outside the physiological 
value were discarded. 
Once imaging protocol was set in order to maximize signal acquisition and 
resolution, a first evaluation of rsfMRI method at 4.7 T was done in a group of 
healthy mice (n=15). Image processing was focused first on rodent anatomical atlas 
and functional atlas, with the same approach on FSL suite (Gozzi and Schwarz, 
2016). Brain was segmented in order to extract the whole cortex and brainstem, 
including the hippocampal area and excluding the cerebellar-ventral medullar 
regions to define mouse brain networks.  
The preliminary choice on the cortex and brainstem was made to compare 
previously reported studies (Granjean, 2017), in which resting state mouse 
networks focused in these macroareas. By means of independent component 
analysis (ICA), Indipendent Components (ICs) were found matching networks from 
the somatosensory, motor limbic and default mode areas compatible with functional 
connectivity (FC) values of healthy and EAE mice were detected in a limited 
number of regions. 
 
 
 
Figure 3.2.2: Functional connectivity networks after FSL analysis, in healthy mice. Bilateral areas 
are shown in hot color and overlapped to T2w reference brain atlas. 
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3.2.2 EAE by MOG/Ptx immunization score disease and rsfMRI outcomes 
EAE score in mice is reported in Fig. 3.2.3. Disease signs were daily monitored and 
averaged until the end of the rsfMRI experiment. Major clinical signs in MOG 
immunized mice were hind limb paralysis and complete tail tone loss from 13 days 
post immunization (dpi). Partial recover from paralysis was observed at 20 dpi. 
Coordination along space was preserved and no signs of ataxia were present. Mice 
with atypical and malfunctional behaviour, such as stereotypies, circling or jumping 
were excluded from the study. 
 
Figure 3.2.3 mean clinical score for EAE mice. Evaluations were performed before image 
acquisitions. B) T2w images of one EAE versus, controls, not immunized mouse (CNT) at the peak 
of the disease. Change of contrast (pointed with red arrows) through the lateral ventricle (upper 
image) and cerebral acqueduct (lower image) is visible in EAE mice. 
Control mice under anaesthesia regime during the rsfMRI protocol exhibited as well 
as EAE the same decrease in body temperature across MRI pipeline during 
anestesia protocol. Respiration rate (breaths per minute, bpm) monitored during the 
acquisition did not show significant variability between the two considered groups 
(Fig 3.2.4). 
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Figure 3.2.4. Breath rate per minute (bpm) expressed in y axis for the two groups as mean values + 
SEM. Different isoflurane concentration administered during rsfMRI experiment are shown below. 
EAE versus not immunized mice as controls (CNT). No statistical differences were found. 
 
In Figure 3.2.5 the Pearson correlation coefficients for EAE and CNT are reported 
in a single matrix exploiting the symmetry of the matrix itself. In the following, the 
mean Pearson correlation coefficients will be referred to as Functional Connectivity 
(FC).  
The FC matrices obtained for 54 ROIs showed different BOLD signal correlation 
patterns. It is noticeable a slightly increase in Pearson correlation coefficients in 
areas corresponding to the midbrain in mouse: inferior colliculus, inferior olivary 
complex, pontine nucleus, superior olivary complex, periaqueductal grey, medulla 
oblongata, midbrain, pons, interpeduncular nucleus and ventral tegmental 
decussation (Fig. 3.2.6).  
The plain differences between obtained coefficients, as correlation values of EAE 
minus correlation values of CNT for each equal brain region, were also reported for 
visual inspection of functional connectivity networks in brain. In Figure 3.2.6 A, 
connectivity differences were negative in some regions, positive or near zero. For 
equal correlation values between EAE and CNT, it means that there are no 
differences in functional connectivity between the two groups, in the same area. It 
is possible with plain differences matrix to distinguish brain macroareas related to 
functional networks, not necessarily anatomical contiguous. To investigate if there 
were statistical significant differences in functional connectivity behaviour between 
not immunized mice and EAE, multiple comparisons test were performed. All 
considered correlations between regions were compared, applying false discovery 
rate correction. For multiple comparison test, p values below 0.05 were accepted as 
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significant. First, functional connectivity differences between groups were 
thresholded. Brain regions which differences calculated as EAE – CNT (correlation 
values) below 0.5 were excluded. Statistical analysis focused on 10 regions, from 
different functional network. In Fig. 3.2.6 B multiple comparison results are 
reported as p values for brain areas included in basal, brainstem, cerebellum, cortex, 
somatosensory functional network. Also white matter areas were included, because 
of their correlation values differences.  In particular, there was not significant 
changes in the white matter correlated to sensory network, while the brainstem and 
the cortex network connectivity were different between groups.  
 
Figure 3.2.5. Pearson correlation analysis of BOLD strength signal, connectivity matrix; positive 
Z-Fisher transformed values. Half matrix below represents not immunized mice, as controls (CNT) 
while half matrix above the EAE mice, at chronic stage. Brain regions corresponded to Allen 
Mouse Brain Atlas, from Institute for Brain Science (AIBS), Common Coordinate Framework 
space (adapted for 4.7T resolution; CCF v3, © 2004 AIBS. Available from: http://www.brain-
map.org/). Abbreviations are the following: abv= arbor vitae of cerebellum, aca=Anterior part 
commissure, Acb= nucleus accumbens, acp= posterior part commissure, Amg =Amygdala, 
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Au=Auditory cortex, BF= Basal Forebrain, BNST=Bed nucleus of stria terminalis, cb=cerebellum 
Cg=Cingulate anterior, Cu=Cuneate nucleus, Enth=Enthorinal region, cp= cerebral peduncle, 
Cpu= Caudate putamen, DG=Dentate gyrus, ,fi=fimbria, Fro=Frontal lobe, Fs= Fundus of 
striatum, fx=fornix, GP=Globus Pallidus, hbc=Habenular commissure, Hi=Hippocampus, 
Hy=Hypotalamus, IC=Inferior colliculus, IO=Inferior olivary complex, LS=Lateral septal 
complex/nucleus MB=Midbrain MC=Motor cortex, mlf= Medial longitudinal fasciculus ,MSC = 
medial septum, mt= mammillothalamic tract, OL=Occipital lobe, Olf=Olfactory bulb, opt=Optical 
tract, PAG=Periacqueductal grey, Pas=Parasubiculum, Pir=Piriform cortex, Pn=Pontine nucleus, 
Pons=Pons, Ptl=Parieto temporal lobe, RS= Retrosplenial cortex, SC= Superior colliculus, sm= 
stria medullaris, SOIC= Superior olivary complex, Ss= Somatosensory cortex, st=Stria terminalis, 
Th=Thalamus, Tu=olfactory tubercle, vgtx=ventral tegmental area.  
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Figure 3.2.6 A) Connectivity strength differences matrix between EAE versus CNT, expressed in 
normalized values. B) Magnified representation of significative functional brain areas with lower 
triangle showing FC strength differences, in not immunized mice, versus EAE, at chronic stage. 
For each square, upper triangle represents p-values from multiple comparison analysis, thresolded 
to p = 0.05. Also functional network location (horizontal bar) vs anatomical location (vertical bar) 
is reported, referring to selected brain regions (short labels). 
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Connectivity strength was also reported for couple of regions from distinct 
functional networks (Fig. 3.2.7). The activity in the cortex increased in EAE mice 
as well as in the brainstem areas, involving the somatosensory area (indicated in the 
sensory network). 
 
 
Fig. 3.2.7 Correlation strength between significant pairs of regions from different functional 
networks. Pearson coefficents from not immunized controls (CNT) and EAE mice were reported 
ad absolute values. Abbreviations are the following: abv= arbor vitae of cerebellum, aca=Anterior 
part commissure, Acb= nucleus accumbens, acp= posterior part commissure, Amg =Amygdala, 
Au=Auditory cortex, BF= Basal Forebrain, BNST=Bed nucleus of stria terminalis, cb=cerebellum 
Cg=Cingulate anterior, Cu=Cuneate nucleus, Enth=Enthorinal region, cp= cerebral peduncle, 
Cpu= Caudate putamen, DG=Dentate gyrus, ,fi=fimbria, Fro=Frontal lobe, Fs= Fundus of 
striatum, fx=fornix, GP=Globus Pallidus, hbc=Habenular commissure, Hi=Hippocampus, 
Hy=Hypotalamus, IC=Inferior colliculus, IO=Inferior olivary complex, LS=Lateral septal 
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complex/nucleus MB=Midbrain MC=Motor cortex, mlf= Medial longitudinal fasciculus , mt= 
mammillothalamic tract, OL=Occipital lobe, Olf=Olfactory bulb, opt=Optical tract, 
PAG=Periacqueductal grey, Pas=Parasubiculum, Pir=Piriform cortex, Pn=Pontine nucleus, 
Pons=Pons, Ptl=Parieto temporal lobe, RS= Retrosplenial cortex, SC= Superior colliculus, sm= 
stria medullaris, SOIC= Superior olivary complex, Ss= Somatosensory cortex, st=Stria terminalis, 
Th=Thalamus, Tu=olfactory tubercle, vgtx=ventral tegmental area.  
For the between-group analysis, correlation matrix did not show particular pattern 
or huge brain network disruptions. Only some values are significant when EAE 
group was compared to controls at 20 days post immunization. Also independent 
component analysis was performed and ICs averaged per group. 25 IC were 
selected. GiftICA analysis showed significant components related to functional 
networks such as DMN and cortex (Fig. 3.2.8). Increased connectivity is found in 
EAE mice in other cortical areas, as well as in the brainstem. In particular, this 
analysis showed a connectivity component also at the extremities of the cerebellar 
area. 
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Figure 3.2.8. Functional connectivity networks by means of GiftICA. Survived Indipendent 
components (ICs) are shown overlayed onto the reference brain atlas. EAE mice (hot) and not 
immunized controls CNT (cool). ICs were Fisher z-score normalized (Z). 
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3.2.3 SOD-1 (G93A) transgenic mouse clinical score assessment 
All animals were evaluated from the 50th day postborn, by means of the scale used 
in section 2.3, material and methods. PGE (paw grip extesion) and rotarod test were 
monitored to plan the MRI acquisitions at two different time points. Animals were 
considered at clinical onset at 85±5 days, end stage at 120±5 days postborn, 
accordingly to recorded values reported below (Fig. 3.2.3.1). 
 
 
Figure 3.2.3.1. SOD1(93A) mice group monitored by means of paw grip extension (grip test) 
rotating rod endurance (rotarod test) expressed in seconds ± SEM during the overall study. Also 
weight was monitored and compared to control pool (WT). 
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3.2.4 rsfMRI acquisitions in  SOD-1 (G93A) transgenic mouse 
Physiological parameters under rsfMRI experiment, such as body temperature, 
breath rate and pCO2, were monitored. The breath rate did not exhibit statistical 
differences between SOD-1 (G93A) transgenic mice and wild type control mice 
even at the end stage of the disease. No difference was also observed under different 
isoflurane concentrations (unpaired t-test analysis, Fig. 3.2.4.1). Body temperature 
and pCO2 remained within acceptable limits. The experimental finding that no 
variations in physiological parameters occurred between WT and two different 
stage of disease in SOD mice, allows us to assume that BOLD signal was acquired 
without confounding parameters at free breathing regime. 
 
Figure 3.2.4.1 Mean values of measured breath rate per minute mice groups, SOD (at onset and 
endstage) WT controls, respectively, with different anesthesia regimes under rsfMRI experimental 
protocol. 
Pathological alterations in brain of SOD-1 (G93A) mice were evaluated in T2w 
images that are acquired during the rsfMRI protocol after EPI acquisition (Fig. 
.2.4.2). Lesions appeared as hyperintense areas in T2w images in regions of the 
brainstem corresponding to the trigeminal and facial motor nuclei in 90- and 120-
day-old mice. 
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Figure 3.2.4.2. T2 weighted images of coronal section from two representative mice. Right image 
show a control mouse, versus SOD at right , at onset stage. in SOD is visible a hyperintense region 
corresponding to interpeduncular nucleus, involved in the motor neuron system. 
Correlation of BOLD signal per region across group were evaluated with p < 0.005 
accepted as significant by means of Pearson correlation analysis. Results are 
reported in Figure 3.2.4.3. 
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Figure 3.2.4.3. Pearson correlation matrices between different brain regions of interest, mean over 
all the two involved groups. The SOD group correlations are represented in the upper half of the 
matrix, while below were plotted correlations between brain regions in control (WT) mice, at the 
same age. SOD versus WT controls matrices of BOLD signal were calculated at onset stage A) 
and at the end stage of the disease B). Abbreviations are the following: abv= arbor vitae of 
cerebellum, aca=Anterior part commissure, Acb= nucleus accumbens, acp= posterior part 
commissure, Amg =Amygdala, Au=Auditory cortex, BF= Basal Forebrain, BNST=Bed nucleus of 
stria terminalis, cb=cerebellum Cg=Cingulate anterior, Cu=Cuneate nucleus, Enth=Enthorinal 
region, cp= cerebral peduncle, Cpu= Caudate putamen, DG=Dentate gyrus, ,fi=fimbria, 
Fro=Frontal lobe, Fs= Fundus of striatum, fx=fornix, GP=Globus Pallidus, hbc=Habenular 
commissure, Hi=Hippocampus, Hy=Hypotalamus, IC=Inferior colliculus, IO=Inferior olivary 
complex, LS=Lateral septal complex/nucleus MB=Midbrain MC=Motor cortex, mlf= Medial 
longitudinal fasciculus , mt= mammillothalamic tract, OL=Occipital lobe, Olf=Olfactory bulb, 
opt=Optical tract, PAG=Periacqueductal grey, Pas=Parasubiculum, Pir=Piriform cortex, 
Pn=Pontine nucleus, Pons=Pons, Ptl=Parieto temporal lobe, RS= Retrosplenial cortex, SC= 
Superior colliculus, sm= stria medullaris, SOIC= Superior olivary complex, Ss= Somatosensory 
cortex, st=Stria terminalis, Th=Thalamus, Tu=olfactory tubercle, vgtx=ventral tegmental area.  
In order to get visual and qualitative findings from these data, the simple difference 
between between obtained Pearson’s coefficients is reported below for the two 
B 
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disease stages, versus age-matched controls. Qualitatively we can appreciate a 
general decrease of FC in regions belonging to cerebellum and brainstem (see the 
blue part of matrix reported in Figure 3.2.4.4 A). To assess if there were statistical 
relevant changes between these regions, multiple comparisons test was performed 
for macro-regions similar to what performed in section 3.2.1. In particular, also the 
anatomical regions that included hyper intense T2 weighted signal in the brainstem 
was added to this analysis. Brain regions in which extracellular superoxide 
dismutase (EC-SOD) is expressed, such as hilar region of hippocampus, i.e. dentate 
gyrus, thalamic region and inferior olivary complex were included in the multiple 
comparison analysis (Fig. 3.2.4.4 B). 
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Figure 3.2.4.4. A) Connectivity differences between SOD mice and WT controls expressed as 
correlation values, for the two different stage of the disease (A). First symmetrical matrix 
represents differences between SOD at onset stage and second matrix below SOD at end stage 
minus WT mice age matching. Abbreviations are the following: abv= arbor vitae of cerebellum, 
aca=Anterior part commissure, Acb= nucleus accumbens, acp= posterior part commissure, Amg 
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=Amygdala, Au=Auditory cortex, BF= Basal Forebrain, BNST=Bed nucleus of stria terminalis, 
cb=cerebellum Cg=Cingulate anterior, Cu=Cuneate nucleus, Enth=Enthorinal region, cp= cerebral 
peduncle, Cpu= Caudate putamen, DG=Dentate gyrus, ,fi=fimbria, Fro=Frontal lobe, Fs= Fundus 
of striatum, fx=fornix, GP=Globus Pallidus, hbc=Habenular commissure, Hi=Hippocampus, 
Hy=Hypotalamus, IC=Inferior colliculus, IO=Inferior olivary complex, LS=Lateral septal 
complex/nucleus MB=Midbrain MC=Motor cortex, mlf= Medial longitudinal fasciculus , mt= 
mammillothalamic tract, OL=Occipital lobe, Olf=Olfactory bulb, opt=Optical tract, 
PAG=Periacqueductal grey, Pas=Parasubiculum, Pir=Piriform cortex, Pn=Pontine nucleus, 
Pons=Pons, Ptl=Parieto temporal lobe, RS= Retrosplenial cortex, SC= Superior colliculus, sm= 
stria medullaris, SOIC= Superior olivary complex, Ss= Somatosensory cortex, st=Stria terminalis, 
Th=Thalamus, Tu=olfactory tubercle, vgtx=ventral tegmental area.  
 
Fig. 3.2.4.4 B) multiple comparison analysis in sub areas of mouse brain between groups. For each 
square, upper triangle represents p-values from multiple comparison analysis, thresolded to p = 
0.05. Also functional network location (horizontal bar) vs anatomical location (vertical bar) is 
reported, referring to selected brain regions (short labels). CTX = cortex, WM = white matter, BS 
= brainstem; CER/BS = cerebellar/brainstem area 
A further evaluation was made comparing correlation strength between pairs of 
regions from different functional networks investigated.  (Fig. 3.2.4.5). At the end 
stage of the disease, there is an increase in correlation strength in the default mode 
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network and the cortex, except for the dentate gyrus / globus pallidus pair. A 
decrease in strength is visible in the cerebellar network GrDG/Cb pair, respectfully 
the onset stage. 
 
Figure 3.2.4.5 Connectivity strength comparisons between the two disease stages, respectfully to 
WT control mice FC at the same age. EC/SOD network is defined as pairs of brain regions 
involved in the enzymatic expression of the superoxide dismutase (EC) and where the hyper 
intense T2w areas were found in SOD mice at each stage. 
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GifICA results are shown in the panel below (Fig. 3.2.4.6); mean ICs from SOD 
mice and WT as controls were superimposed to anatomical rescaled Dorr reference 
atlas from section 2. ICs changed at onset and end stage in the cortical network; the 
cerebellar network showed ICs also. At the end stage, an additional IC is found 
overlapping the DMN but not somatosensory network, while ICs in the thalamic 
network were present only at onset stage.  
  
Figure 3.2.4.6 GiftICA ICs for groups at onset (hot) and end stage (violet) SOD mice versus WT 
(cool color coded) overlapped to the anatomical reference. ICs were Fisher z-score normalized (Z). 
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4. Discussion 
 
4.1 Autoimmunity induced by adoptive transfer of Th17 cells: considerations 
about EAE model 
 
The first part of the Results Chapter of the present thesis is dedicated to the findings 
in ex-vivo brain imaging and histology of the experimental model of EAE by 
adoptive Th17 cells transfer. Tg 2D2 mouse represents one of the chronic 
preclinical models initially used for investigation of optic neuritis. Lymphocytes 
from Tg 2D2 mice express the ability to change CD4+ cell subtype, polarizing them 
as Th17 precursors in vitro. It was reported that encephalopatogenity of Th17 
populations is dependent upon cytokines secretion and can be disease effectors also 
in ocular inflammation in mice (Che, Chauhan, Shao et al, 2017), suggesting the 
passage of Th through the blood brain barrier. 
In vitro Th17 cells can change the severity of the disease, because they possess the 
ability to produce also high levels of INF-y/Il-17, as it was assessed in this study by 
means of cytofluorimetry. This EAE model has features similar to symptoms of 
chronic MS. In the wide range of disease signs that are present in human MS, this 
model can reproduce balance problems or dizziness, and brain plaques. The 
combination of typical and atypical symptoms, previously reported and scored, is 
suggested by polarization/changing of Th17 into Th1. It is known that presence of 
Th1 induces EAE typical symptoms, that are related to hind limb paralysis and high 
level of inflammation in the spinal cord mostly (Domingues, 2010). In this model, 
neuropathological signs are visibile from the 10th day post injection. 
Encephalopathogenity of injected Th17 cell is not immediately expressed. This 
latency in EAE clinical signs suggested the hypothesis of interdepency, in the 
inflammatory process, of anatomical districts near the site of injection with Th17 
cells. Duc et al. in 2019, reported in the same EAE model that gut microbiota can 
modulate the inflammatory outcome. In this paper was demonstrated that i.p. 
injected Th17 cells infiltrated the lamina propria in the mice gut, before reaching 
the CNS. These results could explain the dampering of the EAE symptomps in the 
used model, i.e. typical signs in mice mixed with atypical, and not always presents 
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with the same intensity within subjects. Noticeable disease signs, that can be scored, 
are modulated by gut microenvironment in the first days p.i.. 
Histological findings showed the ability of injected Th17 cells to reach the CNS 
and recruit CD3 population, and MAC3/CD4 as well. The different cells infiltrates 
were detected in microphotographs mostly at the cerebellar and medulla oblungata 
areas, leading to focus on these brain regions while analyzing DTI results.  
 
4.2 MRI correlates in EAE by adoptive transfer of Th17 cells: considerations 
about advantages and disadvantages of ex-vivo methods. 
 
Neuroimaging findings were obtained in ex vivo fixed samples.  Several 
experimental procedures required careful optimization in order to obtain 
meaningful results. Reported values from DTI in results section (3.1.3), for different 
brain areas ex-vivo are lower than in–vivo published ones in mice (Zhang, 2010). 
Because of overall lower diffusivity, higher b-values were needed to acquire 
meaningful data in the diffusion sequence with resulting low SNR. Moreover 
multiple b-values in DWI resulted in long acquisition times and therefore were 
possible only in ex-vivo experiments. 
Another issue is represented by the perfusion procedure. Ex vivo and fixed brain 
tissues exhibit reduced T1, T2, and alterations in diffusivity, comparing the same 
tissues in vivo. Water relaxation is altered by fixative agents (formalin or PFA) and 
by tissue lower temperature than a living subject body (Sheperd, Thelwall et al., 
2009). This means that fixed specimens, independently of pathology under 
investigation, compared to in-vivo, have reduced contrast to noise ratio in MRI.  
Moreover, post-mortem interval (i.e. the time interval elapsed between sacrifice and 
tissue fixation) may irreversibly affect the microstructure of the tissue. Therefore, 
fixation via perfusion occurred at pre-mortem stage, by means of intracardial 
injection of fixative. However, the risk that the applied pressure of pumping could 
have induced microscopic damage in brain tissue and therefore introduced artefacts 
in the MR images remains.  
DWI acquired with high number of b values at high magnetic field, showed that 
only fractional anisotropy (FA) and axial diffusivity (AD) were statistically 
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significant, if measured in large brain areas, healthy mice compared to EAE. ROI 
based methods gave more evidence of changing of the other metrics, such as T1 and 
T2 times, RD and MD. This could be related to the predominant location of the 
lesions, medulla oblongata and arbor vitae area. 
DWI measurements performed at high resolution showed statistically significant 
differences between EAE and healthy controls only in the fractional anisotropy 
(FA) and axial diffusivity (AD) parameters. In T1w and T2w images, the 
identification of lesions, asymmetrically distributed along the brainstem, was 
difficult. Moreover, histological results demonstrated high variability of 
inflammatory load and demyelination in the EAE subjects. Such heterogeneity in 
the inflammatory load and demyelination is detectable also in the spinal cord. 
 
4.3 RsfMRI methodology at 4.7T: considerations about the overall experimental 
setup 
 
Preliminary results from low magnetic field, respectfully to the state of the art in 
preclinical functional neuroimaging, showed that connectivity networks such as 
DMN, Sensory, Basal, Cerebellar and Brainstem (Liska, Galbusera, Schwarz  et al., 
2015)  can be recovered at 4.7 T.  
Major hindrances with EPI acquisition sequences are represented by long TE and 
image distortions.  Acquired BOLD signal is dependent from anaesthesia regime, 
that was similar to previously reported studies, in which low doses of isoflurane 
does not affect brain cortical networks (Grandjean, Schroeter et al., 2014).  
Physiological parameters were monitored and remained within physiologically 
acceptable range, despite free breathing (not forced ventilation) of mice.  
Medetodimine is a-adrenegic agent (Sinclair, 2003), but may lead to side effects in 
the long time, that were controlled reducing at 10 minutes the overall EPI 
acquisition. Combined isoflurane and medetomidine regime seemed to not affect 
breath rate and oxygenation, between groups, in the two different experiments, 
probably because of short gaseous anaesthesia induction time.  
Functional networks identified by means of  FSL MELODIC enlightened 
significant correlations between cortical areas and somatosensory/brainstem 
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networks. This method was used preliminarly to assess feasibility of 4.7T for 
resting state experiments. All found networks from functional brain atlas and 
analysed by means of ICs are preserved, confirming previous study in which 
stationary functional connectivity at 1.1% isoflurane is still detectable in mice 
(Bukhari, Schroeter and Rudin, 2018).  Spontaneous head movements causes 
fluctuation of signal that can be excluded as confounding, thanks to FSL/SPM 
corrections and data cleaning. Two software were used to pre-process, smooth and 
clean all the datasets. One flexible, SPM combined with GIFTICA, and one less, 
FSL, combined with MELODIC without differences in pre-processing pipeline, 
because of the algorithms shared in common between toolboxes. Choice of SPM 
tool for main experiments with EAE and SOD was made to include more brain 
areas and select respective functional networks. Moreover FSL is tailored for 
human brain studies, and focusing on cleaning signal components on BOLD that 
reflects different conditions comparing to mouse brain. Automation in processing 
FSL pipeline would require high knowledge of good/bad signal in resting state. In 
this study, no ventilation to mice was applied. Thus physiological parameters, such 
as temperature and bpm under anaesthesia should be included in the pre-processing 
in further studies, with more animals. However, major functional rs mouse brain 
networks reported in literature, disrespectfully of selected software, can be 
observed and recovered at 4.7 T. 
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4.4 rsfMRI correlates in EAE mice by MOG/Ptx immunization 
 
Obtained data suggested that alterations in FC are detectable in EAE mice also at 
low magnetic field. A general trend toward an increase in FC was observed in EAE 
mice at the 25th day post induction. Most of the elements in the correlation matrix 
were below the threshold of significance, while some regions were significantly 
functionally correlated and differed between the two groups. It is very interesting 
that FC in the regions that defines cortex network increases in EAE animals 
(compared to CNT). The anatomical distribution of the region pairs showed that the 
FC increase was relative to anatomically contiguous brain regions (retrosplenial 
cortex, enthorinal region, frontal lobe). In particular, a loss in connectivity strength 
was found in cerebellum – inferior colliculus – motor cortex areas (see fig.3.2.6 in 
result section, in which Frontal lobe –Thalamus, Motor cortex – inferior colliculus 
and cerebellum - pairs showed decreased FC). This is consistent with previous 
studies in which MS patients had both decreased and increased values of FC. 
In recently reviewed FC data in MS, specific brain areas of many resting state 
networks showed that patients with clinically isolated syndrome have a higher FC 
than in either healthy subjects or relapsing-remitting MS, even though gray matter 
and white matter integrity are preserved (Tahedi, Levine, Greenlee et al., 2018). 
These findings are generally interpreted as a compensatory phenomenon: the 
coherence of cerebral activity increases at the earliest stages of the disease to limit 
the functional impact of structural damage but is subsequently lost in the late phase 
as a result of the progression of brain damage. It has been reported that brain 
reorganization, as expressed by changes in FC, is probably a dynamical process 
along the disease course and consequently we should consider the possibility that 
FC alterations could be slower than the evolution of the disease. It is unknown if 
these alterations could change between relapsing or remitting phase, or when the 
lesion is active. To date, longitudinal studies on humans are focused on VBM, 
perilesion area examination by means of other MRI techniques, with more attention 
on structural changes (Filippi, Rovasi and Rocca, 2004).  
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4.3 rsfMRI correlates in ALS SOD93A model 
 
The necessity to define new biomarkers in the Amyotrophic Lateral Sclerosis (ALS) 
disease leads to combine new techniques with the available preclinical model in 
longitudinal studies.  The transgenic line SOD1 (G93A) has histopathological 
outcomes similar to familiar and sporadic form in human beings, such as 
neuromuscular dysfunction, axonal and mitochondrial damage in spinal cord, while 
no significative features were reported in the brainstem and cerebellar/medullar 
region (Dal Canto and Gurney, 1997).  We decided to monitor two stages of the 
disease, when early and severe motor deficits were accurately defined, to find 
functional correlates useful in future for non–invasively therapies testing. 
Moreover, motor neuron circuitry involves cortex and spinal cord. While alterations 
induced in the spinal cord have been widely investigated also in other 
neurodegenerative diseases, how the progression of the disease affects cortex is 
poorly understood. Studies reported in the literature focused on ALS using fMRI 
and rsfMRI combined to other brain activity measurements. To date, theories on 
compensatory events in the cortex, as well as inhibitions or dysfunction in some 
areas were reported (Proudfoot, Bede and Turner, 2019). 
  
The SOD93A ALS model develops motor paralysis because of denervation of the 
neuromuscular junction. Ventral root axons and loss of alpha motor neurons are 
involved in the observed motor deficits. In particular, such neurons are located in 
the ventral tegmental area, (vgtx) and are connected to lower motor neuron circuit. 
The upper motor neurons, that are in the motor cortex, can receive inputs from long 
distance, through the corticospinal tract (for an extensive review, see Liang, 2011). 
These neurons have a long distance input also with thalamo-cortical neurons, as 
well as they receive cortical inputs (Sheperd, 2013). Upper  motor neuron innervate 
also the spinal cord, but the connection between brain cortex and spinal cord is 
important to understand the model considered.  
At onset stage, our results show connectivity increased towards the cerebellar area, 
while decreased towards the somatosensory cortex. This could be useful to identify 
a vulnerability period in the preclinical research, in which prodromal symptoms are 
85 
 
not evident, and studying effectiveness of new therapies in the murine ALS model 
from different perspectives across time. Moreover, BOLD signal correlation loss 
across networks is more evident at onset than at end stage. It is interesting to note 
that functional connectivity change is related to the cortex, coupled with midbrain 
area, in which hyper intense region were detected in T2w images on SOD1 mice. 
One hypothesis could be the presence of compensatory phenomenon in default 
mode network and cortex.  
 
Networks revealed by rsfMRI are related to loss of connectivity strength in some 
pairs of regions, such as dentate gyrus paired with caudate putamen, and 
cerebellum. Interestingly, an increase in connectivity strength was found for the 
thalamus-parietal lobe, and cingulate – caudate putamen pairs. These regions are 
related to brain areas in which extracellular superoxide dismutase (EC-SOD) is 
expressed (Oury, 1999). In this report, EC-SOD was observed in neurons of the 
hilar region of the hippocampus (DG), and also histological stainings revealed the 
same enzyme in tanycytes, a specialized cell population in the median eminence of 
the hypothalamus (Lechan, Fekete, 2006). One hypothesis correlates BOLD 
changes in this experiment because of modification of this cell population, because 
they project towards the 3rd ventricle and contact the cerebrospinal fluid (Mullier, 
Bouret, 2010). While is know from literature that tanycytes are involved in the 
hypothalamic-pituitary-thyroid axis in mice (Muellr-Fielitz, Stahr, Bernau et al, 
2017), their role remains to be further investigated. Moreover, the brain areas 
conserved across species involved the thalamic tract, more than the cerebellar areas, 
playing an important role in the control of movement. The ventral region of 
thalamus is interconnected with the globus pallidus, pontine nucleus with afferents 
towards the cerebellum and cortex and somatosensory spinal cord. Moreover, the 
motor neuron network has projections to the brain towards the ventrolateral 
hindbrain (“below the cerebellum”) to regulate motor functions. It is unknown if 
the different SOD1 isoform can affect the mouse brain, modifying also 
connectivity. The loss of connectivity at end stage in the previously reported regions 
is compatible to neuron loss reported in Caron et al. (idem, 2015), in which 
additional hyper-intense imaged brain areas were found at higher magnetic field.  
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5. Conclusions and future developments 
 
The aim of the present thesis was to validate functional biomarkers related to the 
disease evolution in experimental models of neurodegenerative pathologies. It is 
well known that in MS patients health status is not correlated to the number of active 
lesions observed in MRI. The clinical patterns of disease evolution and recovery 
symptoms are highly variable and scarcely correlated with structural CNS damage, 
as detected by MRI. It has been hypothesized that this scarce correlation, that has 
been referred to as clinical/MRI paradox depends on the efficacy of reparative 
mechanisms and interindividual variations in cortical reorganization and for this 
reason, attention was devoted to functional studies. An additional experimental 
model of neurological disease, namely Amyotrophic Lateral Sclerosis, ALS, was 
considered in the attempt to evaluate the potential usefulness of functional studies 
for the diagnosis of this pathology.  
First it was implemented the protocol for resting state fMRI at 4.7T in healthy mice, 
then applied to MS and ALS preclinical models. Moreover, preliminary studies at 
structural level were conducted on Th17-induced EAE model. These experiments 
were conducted to include, in the future, the rsfMRI protocol in a different model 
of MS, that possess a higher degree in neuroinflammation and large brain lesions, 
if compared to the standard MOG-induced EAE.  The two EAE models investigated 
recapitulate different clinical outcomes that are present mostly in chronic MS: a) 
loss of motor function, spinal cord inflammation (EAE MOG model); b) loss of 
motor coordination, mild and severe spinal cord inflammation (EAE Th17 transfer).  
As far as the structural MRI study is concerned, our results show that diffusion 
metrics could represent a suitable marker in early stage of the pathology and could 
be a valuable tool to test new therapeutics if combined with other methods, such as 
flow cytometry of CD cell types. This need is crucial at present especially for 
progressive multiple sclerosis (Ontaneda, Thompson, Fox et al., 2017; Bermel, 
2017).  
In this thesis, a limited number of DTI metrics have been analysed yet.  More efforts 
should be addressed in order to analyse other DTI metrics, including fiber tracking, 
in the cerebellar and brainstem area in mice. Cerebellum and medulla oblongata, in 
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which most of the lesion were found, represent an important and developed area in 
mouse brain, as first anatomical connection to the spinal cord. More efforts could 
be addressed to the study of this area, by means of in-vivo diffusion and rsfMRI, 
because the medulla contains motor and interneuron populations and in Th17-
induced EAE lesions are prominent in that brain portion.  
In EAE Th17 transfer model inflammatory foci are driven by CD3/CD4 cells, while 
in MS patient also a source of inflammation is due to CD8. One hypothesis 
suggested is the association with Eptstein-Barr virus (Serafini, Rosicarelli 2019) 
and they represent the predominant population in MS lesions (Hayashi , Morimoto 
, Burks JS, Kerr et al., 1988).  
 
Because of the hetereogeneity of inflammatory cells solicited by 
encephalopatogenic Th17, it would be interesting in future to investigate if there 
are different lesion “stages” in the brain, by means of in-vivo diffusion MRI. 
The EAE model induced by MOG peptide has different clinical outcomes. The 
progression of the disease is slow and lesion are visible at the spinal cord level; 
moreover, imaging the spinal cord in mouse requires high magnetic field and 
expertise. In this work we focused on the CNS; we observed ventricle enlargement 
in anatomical images that suggested an inflammatory response in CNS, compatible 
to microglia activaction in the presymptomatic stage (Valente, Serratosa et al., 
2017). Microglia are the primary immune cells and this cell population can spread 
in the CNS, explaining the brainstem/cortex network increased connectivity in 
chronic stage, as a compensatory phenomenon. A deeper investigation on RSN in 
EAE mice will require higher magnetic fields, always coupled with head coil (at 
7T), in order to compare correctly morphometry with rsfMRI. RsfMRI data could 
be added to MS scoring scale in the clinical field, at the early stages of the disease. 
A recent report in MS patients combining RSN and T2w, suggests two types of 
correlation between FC and neurodegeneration (Castellazzi, DeBernard, Melzer et 
al., 2018). In this study, they suggested that a true compensatory mechanism in 
humans is related to areas of increased FC in the cuneus, precuneus, and superior 
frontal gyrus (structures that are not found in the mouse cortex). This means that 
one part of FC increase could be associated to other factors, as well as not all 
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decreased FC networks are due to neurodegeneration per se. Future research on 
EAE on these basis will need rsfMRI method combined to morphological/structural 
study, for example using VBM, at longitudinal level, with acquisition at more time 
points. 
It is known from the literature that modified SOD1 is representative of up to 10% 
ALS in humans. The autosomal dominant mutation in familial ALS of SOD1 is 
considered as major contributor in this neuropathology, but is still unclear how the 
mutant enzyme causes motor neuron degeneration. It has been recognized an early 
damage in extra motor regions in ALS (Trojisi, Sorrentino et al, 2017).  
Thus, focusing on functional connectivity could elicit other questions on ALS 
pathology progression. Furthermore, there are not methodologies that can diagnose 
this debilitating disease at early stage, when there are not clinical evident signs. 
Obtained results could help understanding also pre-onset stage in SOD1, with the 
help of rsfMRI correlates. Recently, studies focused on early onset signs on SOD1 
mice at 8 weeks of age, with subtle abnormalities in gait while striding a treadmill, 
but habituation of controls to repeated task gave differences between groups 
(Whooley, 2006). At this age, a true motor dysfunction cannot be detected with the 
same test (Guillot, 2008), suggesting a difficulty in reproducibility in motor test at 
pre symptomatic stages, that could be overcome by applying advanced MRI. Also 
the behaviour during SOD1 lifespan was recently analyzed between different 
phenotypes (Kreilaus, 2019). Researchers aimed to test several behavioural 
paradigms before the expected disease onset. Moreover, also spatial memory and 
conditioning were tested comparing male and female littermates versus WT. 
Findings suggested different patterns in SOD1 behaviour, recognition memory and 
response to stimuli before motor impairments. These series of methods could be 
useful to study mice DMN and memory as variables in SOD1 mice, when compared 
to controls, and correlate them to resting state networks. It is important for ALS 
preclinical model to keep in mind that mutant mice yield different genes and should 
be used to address different research questions. 
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In conclusion, in this thesis we have implemented rsfMRI methods in mice and 
obtained preliminary results in two experimental model of brain pathologies, MOG-
induced EAE and SOD-1 ALS. Moreover the Th17-induced EAE model has been 
implemented, histological characterization and structural MRI data obtained.  
At the best of our knowledge, rsfMRI has not been applied yet to EAE and ALS 
experimental models. Results are promising although they need validation at higher 
magnetic fields. Integration of functional and structural MRI methods could provide 
innovative surrogate imaging biomarkers that can constitute a platform to test the 
efficacy of new treatments, or other interventions. Such integration could improve 
the value of already assessed metrics in EAE and ALS and unravel the pathological 
progresses, along the disease evolution.  
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Appendix 
 
This section covers the nomenclature, abbreviations and all reagents used for 
experiments reported in chapter 2.  
A0. Abbreviations 
2D2 MOG35-55 specific TCR 
ALS amyotrophic lateral sclerosis 
B6SJL-Tg(SOD1*G93A)1Gur/J GH1 transgenic mouse B6SJL crossed, high copy 
number gene 
MRI magnetic resonance imaging  
DMN default mode network 
DWI diffusion weighted imaging 
EAE experimental autoimmune encephalitis 
EPI Echo Planar Imaging 
FC functional connectivity 
FUS fused in sarcoma RNA-binding protein 
GE gradient echo  
GRE gradient refocusing echo 
HE Hematoxylin-Eosin 
ICA independent component analysis 
IC(s) independent component(s) 
IHC immunohistochemistry 
i.v. intravenous 
i.p intraperitoneal 
IR inversion time 
LFB Luxol Fast Blue 
PFA paraformaldehyde 
PTx pertussis toxin 
MS multiple sclerosis 
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RBC red blood cell 
RF radiofrequency 
rsfMRI resting-state MRI 
s.c. subcutaneous  
SD standard deviation 
SE spin echo 
SPM statistical parametric mapping 
T1 spin-lattice relaxation time 
T2 spin-spin relaxation time 
TCR T-cell receptor 
TE echo time 
Th17 T-helper 17 
TR repetition time 
 
A1. Differentiation of T-cell in vitro from 2D2 mice 
Adapted from Jaeger A., Kuchroo, 2013. Differentiation of T effector cells, 
uploaded content from Kuchroo laboratory; http://kuchroolab.bwh.harvard.edu/; 
Cell strainer 70um  
CD4 T cell isolation kit (130-104-454 ; Miltenyi Biotec) 
RBC lysis Buffer (00-4333-57; eBioscience) 
FoxP3 transcription factor staining set (00-5523-00, Life technologies) 
MACS LS column (130-042-401; Miltenyi Biotec) 
 
Cytokines/antibodies 
 
hIL-2 (130-093-901; Miltenyi Biotec) 
mIL-12 (210-12-10UG; Peprotech) 
CD45-Amcyan (30-F11 ; 103138 ; Biolegend) 
CD3 APC eFluor 780 (145-2C11; 47-0031-82; eBioscience) 
CD4 alexafluor 700 (GK1.5; 56-0041-82; eBioscience) 
CD44 alexafluor 647 (IM7; 103018; Biolegend) 
IL-17A PE/Cy7 (eBio17B7; 25-7177-82; eBioscience) 
IFNg FITC (XMG 1.2; 53-7311-82; eBioscience) 
RORgT BV421 (Q31-378; 562894; Biolegend) 
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Reagents 
Clone media in DMEM 
Sodium Pyruvate S8636-100ML Sigma 7.5mL 
L-Glutamin (200mM) 5-10K00H Bioconcept 5mL 
Penicilin-Streptomycin solution 4-01F-00H AMIMED 5mL 
NEAA 100x 11140-035 Gibco 5mL 
AA Arginine / Asparagine mix Homemade, see below 5mL 
FA Folic Acid solution Homemade, see below 5mL 
VIT Vitamin mix solution M6985 Sigma 5mL 
2-mercaptoethanol (50uM final) 21985-023 Gibco 455uL 
FCS N/A 50mL 
DMEM 41965-039 500mL 
 
AA Arginine / Asparagine mix 
L-Arginine (11009-25G, Sigma FW: 174,2 g/mol, 0.7mM final)     1,16g 
L-Asparagine (A0884-25G, Sigma FW: 132.1g/mol, 0,3mM final):    0.36g 
Distilled H2O    up to 100mL 
 
FA Folic Acid solution 
Folic acid (F8758-25G, Sigma 14uM final)    0.06g 
1N NaOH (A1551.1000, Applichem)    0.5mL 
dH2O    up to 100mL 
 
MACS Buffer (BSA 0.5%; EDTA 2mM in PBS 1x) 
BSA (A3912-100G; Applichem)    2.5g 
EDTA 0.5M (46-034-Cl; Corning)    2mL 
PBS 1X    up to 500mL 
FACS Buffer (BSA1% in PBS 1x) 
BSA (A3912-100G; Applichem)    5.0g 
PBS 1X    up to 500mL 
A2. EAE MOG/Ptx induced 
complete Freund’s adjuvant (Becton Dickinson)  
Mycobacterium Tuberculosis (Becton Dickinson) 
Pertussis toxin 
 
A3. Anaesthetics and usage in animals  
Perfusion Surgery in PBS 1M PFA 4% 
Ketamine (Ketasol™) 0.6mL 
Xylazine (Rompur™) 2% 0.4 mL 
NaCl saline solution for injections: add up to 10 mL 
Euthanasia  
Barbiturates (Pentobarbital™) not diluted, IV or IP above 100mg/kg; sodium 
pentobarbital 390 mg/ml + sodium phenytoin 50 mg/ml 
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Hypnotic agents, with anaesthetic and analgesic effects with long time recovery 
Agent: Medetomidine in NaCl solution: 0.1%  
Antidote: Atipamezole in NaCl solution: 0.01% 
Anaestethic gases with low effect of analgesia:  
Isoflurane 2-2.5%, in 1lt O2, accordingly to animal weight. 
Isoflurane 1.5%, long time induction (up to 2 hrs) associated to gas vehicles N2 
and O2 in line. 
 
A4. Histology reagents 
 
Equipment 
Oven with adjustable temperature.  
Surgical instruments: forceps, fine and blunt forceps, scissors, razor blades.  
Glass/plastic ware for histology 
Organic solvents: ethanol, isopropanol, isopropyl alcohol, Xylol (UltraClear™ 
clearing reagent, Avantor, Center Valley, USA)  
Humified chamber  
Acrylic brain matrix for coronal tissue sections, mouse brain, Alto 
 
Bieschlowski staining 
 
Development solution: liquid formalin (Merck®), 37% 20 mL  
100 mL destilled water 
0.5g citric acid monohydrate (Merck®) 
15uL nitric at 65% (Merck®) 
2% sodium thiosulfate pentahydrate (Merck®): 4 gr in 200 mL of distilled water 
AgNO3: 250 gr, M = 169.88 (Roth®) 
NH3 at 32% ammonia (Merck®) 
 
LFB-PAS staining 
 
EtOH 100% absolute, then diluted at 90%, 70% in distilled water 
LFB solvent blue, 25 gr in acetic acid (ClinTech® ) 
Schiffs reagent (Sigma Aldrich®) 
Mayer’s Hemalum, Merck 
Lithium carbonate powder, 250 gr, (Merck®) 
Periodic Acid (Sigma Aldrich®) 
Xylene solution absolute (UltraClear™) 
 
IHC  
After dewaxing:  
Antigen retrival: Pascal Citrate pH 6.0 or TRIS EDTA pH9.0; 
Washing Buffer 10x : 100mL in 1lt destilled water; 
Labelled polymer anti-rabbit HRP (Dako Real); 
Substrate Buffer & DAB chromogen (x50) (Dako Real) 
Peroxidase Blocking solution (Dako Rea)l; 
Antibody diluent (Dako Real); 
Antibodies:  
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Polyclonal rabbit anti-Olig2 IgG  
MAC3 Biolegend clone M3/84 coupled with Fab Fragment Fragment Goat anti-
mouse IgG; 
CD4 Rabbit mAb (Cell signalling Dako D7D2Z), CD3 antimouse (Abcam®) 
 
A.5 Generic Pulse diagrams and nomenclature 
 
A pulse diagram is composed by several parts that combine each other to generate 
the image. RF indicates the radiofrequency applied, while gradients (G) are added 
for different purpose to achieve the best spin re-phasing. Gx, Gy, Gz in plane 
directions could be represented in terms of phase encoding, GPE, or frequency 
encoding, GFE. Sometimes readout is separated, RO, also called GFE gradient, that 
is applied when receiver component are turned on. The object is imaged in its 
frequency encoding, because GFE is active during the formation of the echo. 
Signals are generated by resonance effect. Lines represents at each row of the 
diagram the timeline of the events; often the ADC acquisition part and slice 
selection, SS, that include the electronical part of the instrument, are involved in 
the picture. Diagrams can differ in form, but they maintain the concept in a timeline 
once the method, i.e. the sequence, is applied. As rule of thumb, the shape of the 
frequency varies in function of the pulse shape (rectangular, short rectangular or 
block pulses; Gaussian, sinc1, sinc3). The amplitude of the phase encoding 
gradients, slice excitation, is depicted as length in trapezoidal shape. Negative or 
positive follows the z-plane, in which the formalism included the static magnetic 
field, namely B0. Dashed blocks represents the encoding steps. If the pulse diagram 
is read in columns, each symbol in the line represents the event that happens at the 
same time. 
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T2w  
 
Pulse diagram of multi echo spin echo sequence across time; this representation may slightly vary 
across literature. All the lines proceed simultaneously in MRI experiment. The RF reflect angles 
from the reference plane x. Slice is the volume of the object that receives the RF pulses. Phase and 
readout are the encoding parts, while the ADC operates while the signal is detected (Meiboom, 
1958). 
 
 
T1w 
 
 
MPRAGE representation in pulse diagram, one single readout is shown. TE: time of echo; TI time 
of inversion. 
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EPI 
 
General EPI pulse diagram. The sequences can be slightly modified, by means of other gradients, 
maintaining its fast imaging feature. Adapted from Lippincott Williams & Wilkins, 2010. 
 
A.6 Tensor imaging, Rician noise correction 
 
 
DWI relies on physics and mathematics. A series of useful definitions can be found 
more in detail in literature (see Kingsley, 2006). Here brief concepts are reported 
for better understanding mertics obtained in this work.  
Tensor can be calculated from data acquired by means of sensitizing diffusion 
gradients in six or more directions. There are two approaches, named B and H 
matrix extraction: once the tensor is represented as a vector, matrices can extract 
the apparent diffusion coefficient. The B matrix approach combines the different 
signal intensities from b directions set, and includes the signal noise vector. The H 
matrix approach includes normalized gradient components inside, and ADC can be 
directly calculated from encoding schemes without considering the tensor elements. 
Either B and H, when weighted by means of least squares, treat their points as 
acquired accurately. The B matrix approach is more powerful because yield a 
covariance matrix to optimize DTI parameters, and because the signal decay is non 
mono-exponential. B results more flexible than H. H matrix method, when b values 
are more than 6, brings to a non-squared matrix, and the estimate from b=0 average 
signal is already incorporated inside, meaning that weighted least square fit is not 
possible because b = 0 images can not be fitted separately. 
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In both cases, linear least squares fit can be calculated, but noise in DTI data is not 
fully described by errors. The definition of noise relies in the deviation of a 
measured variable. Types of noise are round-off errors, lower than acquired values 
because dependent from digitized signal (voltage). Scatter and variance occurs in 
biological samples, because of heterogeneity of the object. Other source of errors 
are introduced from raw data when computed into parameters, such as absorption 
and dispersion signal. 
This means that noise has a magnitude that exihibits a distribution, called Rician, 
(Dietrich O, Heiland S, Sartor K. 2001; Gudbjartsson and Patz, 1995) and it is taken 
in account in diffusion anisotropy and respective metrics. 
Because biological tissues has also self-diffusion processes, all models used to 
compute tensor, or diffusion anisotropy indices, are dependent from b factors. Thus 
the chosen gradient sampling scheme can affect the diffusion values in the obtained 
images. In this study, noise level were higher and needed further computations to 
label signals as specific. A future milestone in DWI could be new computational 
methods myelin fraction, intra-extra axonal signal fractions in diffusion images. 
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A.7 Table of anatomical regions in mouse brain and abbreviations 
 
 
A) Mouse brain regions (Amg – IP) A) Mouse brain regions (lo – vgtx) 
Abbreviation Long nomenclature Abbreviation Long nomenclature 
Amg Amygdala lo Lateral olfactory tract 
abv Arbor vitae of cerebellum LSC Lateral septal complex/nucleus 
aca Anterior part commissure MB Midbrain 
Acb Nucleus accumbens mlf Medial longitudinal fasciculus 
acp Posterior part commissure MC+ Motor cortex 
Au+ Auditory cortex MO  Medulla oblongata 
BF Basal Forebrain MSC Medial septum 
BNST Bed nucleus of stria terminalis mt Mammillothalamic tract 
cb Cerebellum OL Occipital lobe 
Cg Cingulate anterior Olf Olfactory bulb 
cp Cerebral peduncle opt Optical tract 
Cpu Caudate putamen PAG Periacqueductal grey 
Cu Cuneate nucleus Pas Parasubiculum 
DG Dentate gyrus Pir Piriform cortex 
Enth Enthorinal region Pn Pontine nucleus 
fi fimbria Pons Pons 
Fro Frontal lobe Ptl Parieto temporal lobe 
Fs Fundus of striatum RC Rhinal cortex 
fx fornix RS Retrosplenial cortex 
GP Globus Pallidus SC Superior colliculus 
GrDG+ Granular layer DG sm Stria medullaris 
hbc Habenular commissure SOIC Superior olivary complex 
Hi Hippocampus Ss+ Somatosensory cortex 
Hy Hypotalamus st Stria terminalis 
IC Inferior colliculus Th Thalamus 
IO Inferior olivary complex Tu Olfactory tubercle 
IP Inferior cerebellar peduncle vgtx ventral tegmental area 
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B) Anatomical location 
 
GM                                                                                     WM  Brainstem Cerebellum 
Amygdala 
Anterior part of anterior 
commissure Inferior colliculus 
Arbor vita of 
cerebellum 
Basal Forebrain 
Posterior part of the 
posterior commissure Superior colliculus Cerebellar cortex 
Bed nucleus of stria 
terminalis Posterior commissure 
Corticospinal 
tract/pyramid 
Inferior cerebellar 
peduncle 
Caudate/putamen Cerebral peduncule Cuneate nucleus 
Middle cerebellar 
peduncle 
Enthorhinal area Corpus callosum 
Inferior olivary 
complex 
 
Frontal lobe Fasciculus retroflexus 
Medial 
lemniscus/medial 
lonngitudinal fasciculus 
 
Occipital lobe Fimbria Pontine nucleus  
Dentate gyrus of 
hippocampus Fornix 
Superior olivary 
complex 
 
Fundus of striatum Habenular commissure Periaqueductal grey  
Globus pallidus Internal capsule Medulla  
Hippocampus proper Mammillothalamic tract Midbrain  
Hypothalamus Optic tract Pons     
Lateral septal complex Stria medullaris Interpeduncular nucleus  
Mammillary bodies Stria terminalis 
Ventral tegmental 
decussation 
 
Medial septal complex    
Nucleus accumbens    
Pre-post parasubiculum    
Striatum granulosum of 
hippocampus 
   
Thalamus    
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